| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.632 | 0.012 | 0.64 | 5 Hydroxytryptamine release stimulant | 0.516 0.025 DBMET02488 0.64 0.011 DBMET02489 0.583 0.016 DBMET02490 0.633 0.012 DBMET02491 0.583 0.016 DBMET02492 0.402 0.045 DBMET02495 0.19 0.13 DBMET02496 0.398 0.046 DBMET02497 0.188 0.132 DBMET02498 0.531 0.023 DBMET02494 0.398 0.046 DBMET02493 | DBMET02489 | |
| 0.5 | 0.015 | 0.5 | Cardiotonic | 0.478 0.018 DBMET02488 0.162 0.161 DBMET02489 0.446 0.021 DBMET02490 0.436 0.023 DBMET02491 0.446 0.021 DBMET02492 0.373 0.034 DBMET02495 0.348 0.04 DBMET02496 0.343 0.041 DBMET02497 0.364 0.036 DBMET02498 0.399 0.029 DBMET02494 0.343 0.041 DBMET02493 | ||
| 0.483 | 0.035 | 0.851 | Aldehyde oxidase inhibitor | 0.594 0.02 DBMET02488 0.851 0.004 DBMET02489 0.65 0.013 DBMET02490 0.584 0.021 DBMET02491 0.65 0.013 DBMET02492 | DBMET02489 | |
| 0.41 | 0.014 | 0.46 | Sodium/bile acid cotransporter inhibitor | 0.421 0.012 DBMET02488 0.369 0.029 DBMET02489 0.414 0.013 DBMET02490 0.46 0.006 DBMET02491 0.414 0.013 DBMET02492 0.382 0.023 DBMET02495 0.412 0.014 DBMET02496 0.379 0.024 DBMET02497 0.4 0.017 DBMET02498 0.382 0.023 DBMET02494 0.379 0.024 DBMET02493 | DBMET02491 | |
| 0.391 | 0.013 | 0.693 | Diuretic | 0.335 0.018 DBMET02488 0.355 0.016 DBMET02489 0.358 0.016 DBMET02490 0.36 0.015 DBMET02491 0.358 0.016 DBMET02492 0.565 0.005 DBMET02495 0.565 0.005 DBMET02496 0.596 0.005 DBMET02497 0.642 0.004 DBMET02498 0.693 0.004 DBMET02494 0.596 0.005 DBMET02493 | DBMET02494 | |
| 0.406 | 0.033 | 0.625 | Vasodilator, coronary | 0.409 0.032 DBMET02488 0.473 0.019 DBMET02489 0.412 0.032 DBMET02490 0.383 0.041 DBMET02491 0.412 0.032 DBMET02492 0.598 0.008 DBMET02495 0.255 0.13 DBMET02496 0.622 0.007 DBMET02497 0.271 0.114 DBMET02498 0.625 0.007 DBMET02494 0.622 0.007 DBMET02493 | DBMET02494 | |
| 0.34 | 0.011 | 0.34 | Antiadrenergic | 0.337 0.011 DBMET02488 0.278 0.015 DBMET02490 0.292 0.014 DBMET02491 0.278 0.015 DBMET02492 0.079 0.072 DBMET02495 0.203 0.024 DBMET02496 0.193 0.025 DBMET02498 | ||
| 0.336 | 0.011 | 0.336 | Adrenaline antagonist | 0.334 0.011 DBMET02488 0.274 0.015 DBMET02490 0.288 0.014 DBMET02491 0.274 0.015 DBMET02492 0.076 0.072 DBMET02495 0.2 0.024 DBMET02496 0.19 0.025 DBMET02498 | ||
| 0.317 | 0.007 | 0.395 | Carbonic anhydrase XV inhibitor | 0.346 0.005 DBMET02488 0.181 0.022 DBMET02489 0.395 0.004 DBMET02490 0.348 0.005 DBMET02491 0.395 0.004 DBMET02492 0.239 0.013 DBMET02496 0.089 0.086 DBMET02497 0.29 0.009 DBMET02498 0.091 0.081 DBMET02494 0.089 0.086 DBMET02493 | DBMET02492 | |
| 0.371 | 0.076 | 0.371 | Calpain 2 inhibitor | 0.238 0.158 DBMET02488 0.328 0.097 DBMET02489 0.292 0.119 DBMET02490 0.294 0.118 DBMET02491 0.292 0.119 DBMET02492 | ||
| 0.273 | 0.016 | 0.397 | Alkaline phosphatase inhibitor | 0.311 0.01 DBMET02488 0.142 0.066 DBMET02489 0.328 0.009 DBMET02490 0.286 0.014 DBMET02491 0.328 0.009 DBMET02492 0.283 0.014 DBMET02495 0.33 0.009 DBMET02496 0.337 0.008 DBMET02497 0.397 0.005 DBMET02498 0.258 0.018 DBMET02494 0.337 0.008 DBMET02493 | DBMET02498 | |
| 0.344 | 0.09 | 0.519 | Antiobesity | 0.315 0.106 DBMET02488 0.315 0.107 DBMET02489 0.297 0.118 DBMET02490 0.519 0.033 DBMET02491 0.297 0.118 DBMET02492 0.346 0.089 DBMET02495 0.427 0.056 DBMET02496 0.356 0.085 DBMET02497 0.405 0.064 DBMET02498 0.342 0.091 DBMET02494 0.356 0.085 DBMET02493 | DBMET02491 | |
| 0.238 | 0.003 | 0.358 | Beta adrenoreceptor antagonist | 0.358 0.002 DBMET02488 0.116 0.011 DBMET02489 0.31 0.003 DBMET02490 0.351 0.003 DBMET02491 0.31 0.003 DBMET02492 0.075 0.032 DBMET02495 0.148 0.006 DBMET02496 0.07 0.038 DBMET02497 0.138 0.007 DBMET02498 0.071 0.037 DBMET02494 0.07 0.038 DBMET02493 | DBMET02488 | |
| 0.24 | 0.018 | 0.24 | Cyclin-dependent kinase 3 inhibitor | 0.24 0.018 DBMET02488 0.24 0.018 DBMET02490 0.239 0.019 DBMET02491 0.24 0.018 DBMET02492 0.156 0.084 DBMET02495 0.202 0.032 DBMET02496 0.15 0.096 DBMET02497 0.193 0.037 DBMET02498 0.151 0.094 DBMET02494 0.15 0.096 DBMET02493 | ||
| 0.293 | 0.073 | 0.461 | Spasmolytic | 0.333 0.058 DBMET02488 0.401 0.04 DBMET02489 0.339 0.056 DBMET02490 0.288 0.075 DBMET02491 0.339 0.056 DBMET02492 0.461 0.029 DBMET02495 0.253 0.09 DBMET02496 0.451 0.03 DBMET02497 0.336 0.057 DBMET02498 0.457 0.029 DBMET02494 0.451 0.03 DBMET02493 | DBMET02495 | |
| 0.23 | 0.01 | 0.23 | Calcium antagonist | 0.138 0.027 DBMET02488 0.129 0.03 DBMET02489 0.106 0.044 DBMET02490 0.119 0.035 DBMET02491 0.106 0.044 DBMET02492 | ||
| 0.277 | 0.058 | 0.366 | 5 Hydroxytryptamine uptake stimulant | 0.366 0.021 DBMET02488 0.366 0.021 DBMET02489 0.239 0.092 DBMET02490 0.302 0.044 DBMET02491 0.239 0.092 DBMET02492 | DBMET02489 | |
| 0.227 | 0.01 | 0.347 | Carbonic anhydrase VI inhibitor | 0.321 0.005 DBMET02488 0.161 0.019 DBMET02489 0.343 0.005 DBMET02490 0.307 0.006 DBMET02491 0.343 0.005 DBMET02492 0.138 0.024 DBMET02495 0.237 0.009 DBMET02496 0.157 0.019 DBMET02497 0.347 0.005 DBMET02498 0.187 0.015 DBMET02494 0.157 0.019 DBMET02493 | DBMET02498 | |
| 0.221 | 0.005 | 0.349 | Adrenaline agonist | 0.317 0.004 DBMET02488 0.12 0.025 DBMET02489 0.28 0.004 DBMET02490 0.349 0.003 DBMET02491 0.28 0.004 DBMET02492 0.133 0.02 DBMET02496 0.12 0.025 DBMET02498 | DBMET02491 | |
| 0.212 | 0.013 | 0.494 | Carbonic anhydrase XIII inhibitor | 0.272 0.007 DBMET02488 0.152 0.021 DBMET02489 0.302 0.006 DBMET02490 0.232 0.01 DBMET02491 0.302 0.006 DBMET02492 0.32 0.005 DBMET02495 0.438 0.004 DBMET02496 0.306 0.005 DBMET02497 0.494 0.003 DBMET02498 0.294 0.006 DBMET02494 0.306 0.005 DBMET02493 | DBMET02498 | |
| 0.197 | 0.004 | 0.297 | Beta 1 adrenoreceptor antagonist | 0.264 0.003 DBMET02488 0.097 0.011 DBMET02489 0.231 0.003 DBMET02490 0.297 0.003 DBMET02491 0.231 0.003 DBMET02492 0.114 0.008 DBMET02496 0.104 0.009 DBMET02498 | DBMET02491 | |
| 0.236 | 0.043 | 0.433 | Insulin sensitizer | 0.238 0.042 DBMET02488 0.433 0.005 DBMET02489 0.249 0.035 DBMET02490 0.263 0.028 DBMET02491 0.249 0.035 DBMET02492 0.203 0.07 DBMET02495 0.174 0.102 DBMET02496 0.243 0.039 DBMET02497 0.229 0.048 DBMET02498 0.252 0.033 DBMET02494 0.243 0.039 DBMET02493 | DBMET02489 | |
| 0.207 | 0.015 | 0.305 | Carbonic anhydrase III inhibitor | 0.296 0.005 DBMET02488 0.218 0.013 DBMET02489 0.305 0.005 DBMET02490 0.28 0.006 DBMET02491 0.305 0.005 DBMET02492 0.161 0.025 DBMET02495 0.233 0.011 DBMET02496 0.18 0.02 DBMET02497 0.3 0.005 DBMET02498 0.201 0.016 DBMET02494 0.18 0.02 DBMET02493 | DBMET02492 | |
| 0.199 | 0.018 | 0.201 | Bronchodilator | 0.2 0.018 DBMET02488 0.113 0.05 DBMET02489 0.201 0.018 DBMET02490 0.178 0.023 DBMET02491 0.201 0.018 DBMET02492 0.162 0.027 DBMET02495 0.123 0.043 DBMET02496 0.096 0.068 DBMET02497 0.136 0.037 DBMET02498 0.096 0.068 DBMET02493 | DBMET02492 | |
| 0.205 | 0.032 | 0.205 | Nav1.2 sodium channel blocker | 0.141 0.063 DBMET02488 0.137 0.066 DBMET02490 0.158 0.053 DBMET02491 0.137 0.066 DBMET02492 0.151 0.057 DBMET02496 0.126 0.076 DBMET02498 | ||
| 0.19 | 0.034 | 0.194 | Cyclooxygenase 2 inhibitor | 0.194 0.033 DBMET02488 0.186 0.035 DBMET02490 0.167 0.044 DBMET02491 0.186 0.035 DBMET02492 0.149 0.054 DBMET02495 0.169 0.042 DBMET02496 0.15 0.054 DBMET02497 0.169 0.043 DBMET02498 0.136 0.065 DBMET02494 0.15 0.054 DBMET02493 | DBMET02488 | |
| 0.194 | 0.044 | 0.206 | Cyclooxygenase inhibitor | 0.206 0.04 DBMET02488 0.2 0.042 DBMET02490 0.174 0.054 DBMET02491 0.2 0.042 DBMET02492 0.158 0.064 DBMET02495 0.16 0.063 DBMET02496 0.162 0.061 DBMET02497 0.163 0.061 DBMET02498 0.144 0.075 DBMET02494 0.162 0.061 DBMET02493 | DBMET02488 | |
| 0.152 | 0.005 | 0.237 | Beta 3 adrenoreceptor antagonist | 0.237 0.004 DBMET02488 0.112 0.012 DBMET02489 0.181 0.004 DBMET02490 0.175 0.005 DBMET02491 0.181 0.004 DBMET02492 0.118 0.01 DBMET02496 0.092 0.017 DBMET02498 | DBMET02488 | |
| 0.146 | 0.005 | 0.218 | Beta 2 adrenoreceptor antagonist | 0.218 0.003 DBMET02488 0.084 0.01 DBMET02489 0.202 0.003 DBMET02490 0.209 0.003 DBMET02491 0.202 0.003 DBMET02492 0.086 0.01 DBMET02496 0.083 0.011 DBMET02498 | DBMET02488 | |
| 0.171 | 0.034 | 0.171 | Nav1.6 sodium channel blocker | 0.139 0.067 DBMET02488 0.135 0.073 DBMET02490 0.133 0.076 DBMET02491 0.135 0.073 DBMET02492 | ||
| 0.224 | 0.09 | 0.224 | Calpain inhibitor | 0.197 0.117 DBMET02488 0.206 0.108 DBMET02489 0.181 0.133 DBMET02490 0.197 0.116 DBMET02491 0.181 0.133 DBMET02492 | ||
| 0.25 | 0.125 | 0.669 | Cholesterol antagonist | 0.294 0.095 DBMET02488 0.669 0.01 DBMET02489 0.269 0.112 DBMET02490 0.328 0.074 DBMET02491 0.269 0.112 DBMET02492 0.517 0.03 DBMET02495 0.308 0.086 DBMET02496 0.532 0.028 DBMET02497 0.286 0.1 DBMET02498 0.608 0.018 DBMET02494 0.532 0.028 DBMET02493 | DBMET02489 | |
| 0.21 | 0.087 | 0.37 | Peptidyltransferase inhibitor | 0.251 0.05 DBMET02488 0.24 0.058 DBMET02489 0.228 0.068 DBMET02490 0.247 0.053 DBMET02491 0.228 0.068 DBMET02492 0.362 0.01 DBMET02495 0.181 0.127 DBMET02496 0.351 0.012 DBMET02497 0.37 0.009 DBMET02494 0.351 0.012 DBMET02493 | DBMET02494 | |
| 0.193 | 0.075 | 0.213 | 5 Hydroxytryptamine 3E antagonist | 0.166 0.151 DBMET02488 0.213 0.044 DBMET02489 0.193 0.075 DBMET02491 | DBMET02489 | |
| 0.122 | 0.007 | 0.365 | Carbonic anhydrase XIV inhibitor | 0.169 0.005 DBMET02488 0.059 0.025 DBMET02489 0.216 0.004 DBMET02490 0.108 0.009 DBMET02491 0.216 0.004 DBMET02492 0.287 0.004 DBMET02495 0.114 0.008 DBMET02496 0.365 0.003 DBMET02497 0.123 0.007 DBMET02498 0.361 0.003 DBMET02494 0.365 0.003 DBMET02493 | DBMET02493 | |
| 0.221 | 0.11 | 0.261 | Transcription factor STAT3 inhibitor | 0.261 0.075 DBMET02488 0.197 0.138 DBMET02489 0.239 0.092 DBMET02490 0.236 0.095 DBMET02491 0.239 0.092 DBMET02492 | DBMET02488 | |
| 0.119 | 0.019 | 0.119 | Alpha 1d adrenoreceptor antagonist | 0.081 0.03 DBMET02488 0.057 0.043 DBMET02490 0.057 0.043 DBMET02492 | ||
| 0.2 | 0.105 | 0.374 | Vasodilator | 0.231 0.081 DBMET02488 0.374 0.028 DBMET02489 0.225 0.086 DBMET02490 0.208 0.099 DBMET02491 0.225 0.086 DBMET02492 0.331 0.038 DBMET02495 0.319 0.042 DBMET02497 0.331 0.038 DBMET02494 0.319 0.042 DBMET02493 | DBMET02489 | |
| 0.112 | 0.018 | 0.303 | Carbonic anhydrase XII inhibitor | 0.131 0.015 DBMET02488 0.124 0.016 DBMET02490 0.104 0.019 DBMET02491 0.124 0.016 DBMET02492 0.206 0.008 DBMET02495 0.172 0.01 DBMET02496 0.207 0.008 DBMET02497 0.187 0.009 DBMET02498 0.303 0.005 DBMET02494 0.207 0.008 DBMET02493 | DBMET02494 | |
| 0.115 | 0.023 | 0.273 | Carbonic anhydrase inhibitor | 0.136 0.018 DBMET02488 0.119 0.022 DBMET02490 0.115 0.023 DBMET02491 0.119 0.022 DBMET02492 0.127 0.02 DBMET02495 0.273 0.005 DBMET02496 0.118 0.022 DBMET02497 0.253 0.006 DBMET02498 0.187 0.011 DBMET02494 0.118 0.022 DBMET02493 | DBMET02496 | |
| 0.132 | 0.043 | 0.132 | Alpha adrenoreceptor antagonist | 0.121 0.047 DBMET02488 | ||
| 0.116 | 0.03 | 0.116 | Alpha 1b adrenoreceptor antagonist | 0.105 0.034 DBMET02488 0.063 0.058 DBMET02490 0.063 0.058 DBMET02492 | ||
| 0.088 | 0.005 | 0.123 | Beta 2 adrenoreceptor agonist | 0.123 0.003 DBMET02488 0.069 0.022 DBMET02489 0.114 0.004 DBMET02490 0.122 0.004 DBMET02491 0.114 0.004 DBMET02492 0.076 0.012 DBMET02496 0.073 0.015 DBMET02498 | DBMET02488 | |
| 0.206 | 0.125 | 0.461 | Tyrosine 3 hydroxylase inhibitor | 0.261 0.058 DBMET02488 0.461 0.005 DBMET02489 0.233 0.086 DBMET02490 0.26 0.059 DBMET02491 0.233 0.086 DBMET02492 | DBMET02489 | |
| 0.082 | 0.004 | 0.216 | Beta adrenoreceptor agonist | 0.146 0.003 DBMET02488 0.053 0.013 DBMET02489 0.128 0.003 DBMET02490 0.216 0.002 DBMET02491 0.128 0.003 DBMET02492 0.044 0.038 DBMET02495 0.058 0.009 DBMET02496 0.043 0.039 DBMET02497 0.055 0.011 DBMET02498 0.047 0.025 DBMET02494 0.043 0.039 DBMET02493 | DBMET02491 | |
| 0.083 | 0.007 | 0.083 | Carnitine palmitoyltransferase 1B inhibitor | 0.079 0.008 DBMET02488 0.073 0.01 DBMET02490 0.073 0.01 DBMET02492 0.059 0.018 DBMET02495 0.07 0.011 DBMET02496 0.057 0.02 DBMET02497 0.065 0.014 DBMET02498 0.057 0.02 DBMET02493 | ||
| 0.138 | 0.064 | 0.167 | Cyclooxygenase 1 inhibitor | 0.167 0.049 DBMET02488 0.166 0.049 DBMET02490 0.139 0.064 DBMET02491 0.166 0.049 DBMET02492 0.124 0.076 DBMET02495 0.13 0.07 DBMET02496 0.13 0.07 DBMET02497 0.144 0.06 DBMET02498 0.118 0.083 DBMET02494 0.13 0.07 DBMET02493 | DBMET02488 | |
| 0.08 | 0.008 | 0.08 | Alpha 1b adrenoreceptor agonist | 0.078 0.009 DBMET02488 0.072 0.011 DBMET02490 0.071 0.011 DBMET02491 0.072 0.011 DBMET02492 0.061 0.018 DBMET02496 0.057 0.022 DBMET02498 | ||
| 0.131 | 0.059 | 0.236 | Anesthetic local | 0.103 0.08 DBMET02488 0.236 0.023 DBMET02489 0.114 0.072 DBMET02490 0.111 0.074 DBMET02491 0.114 0.072 DBMET02492 | DBMET02489 | |
| 0.133 | 0.061 | 0.133 | Nav1.3 sodium channel blocker | 0.1 0.097 DBMET02488 | ||
| 0.11 | 0.04 | 0.11 | Alpha 1 adrenoreceptor antagonist | 0.086 0.05 DBMET02488 | ||
| 0.169 | 0.101 | 0.243 | Psychostimulant | 0.195 0.083 DBMET02488 0.243 0.061 DBMET02489 0.162 0.106 DBMET02490 0.162 0.106 DBMET02492 0.2 0.08 DBMET02495 0.168 0.101 DBMET02497 0.147 0.119 DBMET02494 0.168 0.101 DBMET02493 | DBMET02489 | |
| 0.086 | 0.02 | 0.196 | Carbonic anhydrase VB inhibitor | 0.116 0.013 DBMET02488 0.072 0.026 DBMET02489 0.111 0.014 DBMET02490 0.127 0.011 DBMET02491 0.111 0.014 DBMET02492 0.153 0.009 DBMET02496 0.196 0.005 DBMET02498 | DBMET02498 | |
| 0.089 | 0.023 | 0.19 | Carbonic anhydrase IX inhibitor | 0.089 0.023 DBMET02488 0.081 0.026 DBMET02490 0.081 0.027 DBMET02491 0.081 0.026 DBMET02492 0.113 0.017 DBMET02495 0.14 0.013 DBMET02496 0.107 0.018 DBMET02497 0.124 0.015 DBMET02498 0.19 0.009 DBMET02494 0.107 0.018 DBMET02493 | DBMET02494 | |
| 0.094 | 0.029 | 0.256 | Carbonic anhydrase V inhibitor | 0.14 0.017 DBMET02488 0.076 0.038 DBMET02489 0.128 0.02 DBMET02490 0.122 0.021 DBMET02491 0.128 0.02 DBMET02492 0.256 0.004 DBMET02496 0.245 0.005 DBMET02498 | DBMET02496 | |
| 0.087 | 0.025 | 0.087 | ZAP-70 protein tyrosine kinase inhibitor | 0.085 0.028 DBMET02488 0.085 0.029 DBMET02490 0.068 0.05 DBMET02491 0.085 0.029 DBMET02492 0.071 0.047 DBMET02496 0.071 0.047 DBMET02498 | ||
| 0.224 | 0.171 | 0.281 | Beta lactamase inhibitor | 0.249 0.157 DBMET02496 0.281 0.143 DBMET02498 | DBMET02498 | |
| 0.088 | 0.039 | 0.101 | Metalloproteinase-9 inhibitor | 0.101 0.032 DBMET02488 0.085 0.04 DBMET02490 0.083 0.042 DBMET02491 0.085 0.04 DBMET02492 | DBMET02488 | |
| 0.183 | 0.138 | 0.695 | Superoxide dismutase inhibitor | 0.199 0.118 DBMET02488 0.695 0.004 DBMET02489 0.229 0.09 DBMET02490 0.195 0.123 DBMET02491 0.229 0.09 DBMET02492 0.22 0.098 DBMET02496 0.275 0.061 DBMET02498 | DBMET02489 | |
| 0.063 | 0.018 | 0.075 | Carbonic anhydrase IV inhibitor | 0.075 0.013 DBMET02488 0.06 0.019 DBMET02490 0.072 0.013 DBMET02491 0.06 0.019 DBMET02492 0.047 0.027 DBMET02496 0.051 0.024 DBMET02498 | DBMET02488 | |
| 0.072 | 0.028 | 0.13 | Carbonic anhydrase II inhibitor | 0.089 0.022 DBMET02488 0.073 0.028 DBMET02490 0.071 0.029 DBMET02491 0.073 0.028 DBMET02492 0.071 0.029 DBMET02495 0.13 0.013 DBMET02496 0.062 0.034 DBMET02497 0.113 0.016 DBMET02498 0.107 0.017 DBMET02494 0.062 0.034 DBMET02493 | DBMET02496 | |
| 0.076 | 0.032 | 0.076 | Potassium channel (ATP-sensitive) blocker | 0.073 0.036 DBMET02488 0.069 0.042 DBMET02490 0.064 0.051 DBMET02491 0.069 0.042 DBMET02492 | ||
| 0.111 | 0.072 | 0.113 | Sphingosine 1-phosphate receptor 2 agonist | 0.111 0.072 DBMET02489 0.103 0.094 DBMET02490 0.113 0.069 DBMET02491 0.103 0.094 DBMET02492 | DBMET02491 | |
| 0.077 | 0.039 | 0.18 | Carbonic anhydrase VA inhibitor | 0.11 0.021 DBMET02488 0.072 0.044 DBMET02489 0.095 0.027 DBMET02490 0.09 0.03 DBMET02491 0.095 0.027 DBMET02492 0.18 0.006 DBMET02496 0.165 0.008 DBMET02498 | DBMET02496 | |
| 0.079 | 0.042 | 0.111 | Thrombin inhibitor | 0.075 0.048 DBMET02488 0.073 0.051 DBMET02490 0.074 0.049 DBMET02491 0.073 0.051 DBMET02492 0.111 0.021 DBMET02496 0.108 0.022 DBMET02498 | DBMET02496 | |
| 0.042 | 0.005 | 0.089 | Beta 1 adrenoreceptor agonist | 0.089 0.003 DBMET02488 0.027 0.01 DBMET02489 0.072 0.003 DBMET02490 0.088 0.003 DBMET02491 0.072 0.003 DBMET02492 0.028 0.01 DBMET02496 0.025 0.012 DBMET02498 | DBMET02488 | |
| 0.042 | 0.009 | 0.042 | Carnitine palmitoyltransferase 1A inhibitor | 0.038 0.011 DBMET02488 0.027 0.024 DBMET02489 0.035 0.013 DBMET02490 0.035 0.013 DBMET02492 0.032 0.015 DBMET02496 0.029 0.019 DBMET02498 | ||
| 0.063 | 0.033 | 0.123 | Carbonic anhydrase I inhibitor | 0.071 0.029 DBMET02488 0.06 0.035 DBMET02490 0.064 0.032 DBMET02491 0.06 0.035 DBMET02492 0.062 0.034 DBMET02495 0.123 0.013 DBMET02496 0.056 0.038 DBMET02497 0.111 0.016 DBMET02498 0.095 0.02 DBMET02494 0.056 0.038 DBMET02493 | DBMET02496 | |
| 0.053 | 0.025 | 0.08 | Carbonic anhydrase VII inhibitor | 0.071 0.015 DBMET02488 0.08 0.013 DBMET02490 0.062 0.018 DBMET02491 0.08 0.013 DBMET02492 0.042 0.038 DBMET02495 0.041 0.039 DBMET02497 0.053 0.025 DBMET02498 0.046 0.033 DBMET02494 0.041 0.039 DBMET02493 | DBMET02492 | |
| 0.088 | 0.061 | 0.107 | Aminoacyl-tRNA synthetase inhibitor | 0.107 0.038 DBMET02489 0.096 0.049 DBMET02490 0.1 0.045 DBMET02491 0.096 0.049 DBMET02492 0.088 0.063 DBMET02497 0.088 0.062 DBMET02498 0.092 0.056 DBMET02494 0.088 0.063 DBMET02493 | DBMET02489 | |
| 0.03 | 0.004 | 0.159 | Beta 3 adrenoreceptor agonist | 0.08 0.003 DBMET02488 0.01 0.009 DBMET02489 0.064 0.003 DBMET02490 0.159 0.002 DBMET02491 0.064 0.003 DBMET02492 0.01 0.009 DBMET02496 | DBMET02491 | |
| 0.095 | 0.07 | 0.095 | Protease inhibitor | 0.092 0.073 DBMET02488 0.089 0.076 DBMET02490 0.09 0.074 DBMET02491 0.089 0.076 DBMET02492 | ||
| 0.03 | 0.01 | 0.03 | Follicle-stimulating hormone agonist | 0.02 0.019 DBMET02488 0.021 0.017 DBMET02490 0.021 0.017 DBMET02492 0.027 0.012 DBMET02496 0.027 0.011 DBMET02498 | ||
| 0.124 | 0.106 | 0.326 | Anticoagulant | 0.122 0.11 DBMET02488 0.215 0.048 DBMET02489 0.153 0.078 DBMET02491 0.242 0.04 DBMET02495 0.326 0.024 DBMET02496 0.229 0.044 DBMET02497 0.302 0.028 DBMET02498 0.244 0.04 DBMET02494 0.229 0.044 DBMET02493 | DBMET02496 | |
| 0.062 | 0.044 | 0.065 | Trypsin inhibitor | 0.06 0.046 DBMET02488 0.059 0.05 DBMET02490 0.065 0.038 DBMET02491 0.059 0.05 DBMET02492 0.063 0.042 DBMET02496 0.064 0.04 DBMET02498 | DBMET02491 | |
| 0.096 | 0.079 | 0.1 | Factor V inhibitor | 0.1 0.069 DBMET02489 0.097 0.075 DBMET02491 | DBMET02489 | |
| 0.09 | 0.074 | 0.237 | Electrolyte absorption antagonist | 0.098 0.061 DBMET02488 0.237 0.005 DBMET02489 0.119 0.037 DBMET02491 | DBMET02489 | |
| 0.095 | 0.079 | 0.104 | Alpha 2b adrenoreceptor antagonist | 0.104 0.071 DBMET02488 | DBMET02488 | |
| 0.111 | 0.098 | 0.111 | Calcium channel blocker | |||
| 0.051 | 0.038 | 0.052 | Carbonic anhydrase II stimulant | 0.05 0.039 DBMET02488 0.052 0.036 DBMET02491 | DBMET02491 | |
| 0.051 | 0.039 | 0.064 | Vanilloid 2 antagonist | 0.064 0.018 DBMET02488 0.054 0.032 DBMET02490 0.052 0.037 DBMET02491 0.054 0.032 DBMET02492 0.054 0.033 DBMET02496 | DBMET02488 | |
| 0.073 | 0.061 | 0.086 | Metalloproteinase-2 inhibitor | 0.086 0.047 DBMET02488 0.072 0.063 DBMET02490 0.074 0.059 DBMET02491 0.072 0.063 DBMET02492 | DBMET02488 | |
| 0.021 | 0.01 | 0.025 | Follicle-stimulating hormone antagonist | 0.02 0.013 DBMET02488 0.019 0.014 DBMET02490 0.019 0.014 DBMET02492 0.025 0.006 DBMET02496 0.024 0.007 DBMET02498 | DBMET02496 | |
| 0.165 | 0.155 | 0.565 | Hypoglycemic | 0.183 0.13 DBMET02488 0.565 0.01 DBMET02489 0.217 0.098 DBMET02490 0.249 0.077 DBMET02491 0.217 0.098 DBMET02492 0.491 0.016 DBMET02495 0.527 0.013 DBMET02497 0.533 0.013 DBMET02494 0.527 0.013 DBMET02493 | DBMET02489 | |
| 0.026 | 0.019 | 0.028 | Calcium-sensing receptor agonist | 0.028 0.016 DBMET02489 | DBMET02489 | |
| 0.051 | 0.044 | 0.051 | Matrix metalloproteinase (membrane-type) inhibitor | 0.05 0.046 DBMET02488 | ||
| 0.059 | 0.055 | 0.059 | Matrix metalloproteinase inhibitor | 0.058 0.057 DBMET02488 | ||
| 0.031 | 0.028 | 0.052 | Carnitine palmitoyltransferase inhibitor | 0.052 0.007 DBMET02489 | DBMET02489 | |
| 0.112 | 0.11 | 0.195 | Vanilloid 1 agonist | 0.137 0.055 DBMET02488 0.195 0.013 DBMET02489 0.12 0.087 DBMET02490 0.113 0.106 DBMET02491 0.12 0.087 DBMET02492 0.115 0.101 DBMET02495 | DBMET02489 | |
| 0.043 | 0.042 | 0.045 | Metalloproteinase-3 inhibitor | 0.045 0.039 DBMET02489 | DBMET02489 | |
| 0.051 | 0.051 | 0.053 | Kallikrein 1 inhibitor | 0.053 0.045 DBMET02491 | DBMET02491 | |
| 0.03 | 0.031 | 0.051 | Carnitine palmitoyltransferase 1 inhibitor | 0.051 0.007 DBMET02489 | DBMET02489 | |
| 0.062 | 0.065 | 0.075 | Calcium channel L-type blocker | 0.075 0.045 DBMET02489 | DBMET02489 | |
| 0.173 | 0.18 | 0.292 | 12-Lipoxygenase inhibitor | 0.251 0.108 DBMET02488 0.292 0.084 DBMET02489 0.275 0.095 DBMET02490 0.242 0.113 DBMET02491 0.275 0.095 DBMET02492 | DBMET02489 | |
| 0.038 | 0.047 | 0.046 | Matrix metalloproteinase 1 inhibitor | 0.046 0.041 DBMET02488 | DBMET02488 | |
| 0.134 | 0.143 | 0.396 | Non-steroidal antiinflammatory agent | 0.151 0.114 DBMET02488 0.277 0.033 DBMET02489 0.396 0.014 DBMET02495 0.304 0.027 DBMET02497 0.25 0.043 DBMET02494 0.304 0.027 DBMET02493 | DBMET02495 | |
| 0.028 | 0.037 | 0.035 | Factor X inhibitor | 0.035 0.03 DBMET02491 | DBMET02491 | |
| 0.047 | 0.06 | 0.057 | Carbonic anhydrase stimulant | 0.055 0.046 DBMET02488 0.057 0.043 DBMET02489 0.054 0.048 DBMET02491 | DBMET02489 | |
| 0.032 | 0.046 | 0.126 | Factor Xa inhibitor | 0.044 0.034 DBMET02491 0.067 0.022 DBMET02495 0.126 0.01 DBMET02496 0.048 0.031 DBMET02497 0.093 0.015 DBMET02498 0.045 0.033 DBMET02494 0.048 0.031 DBMET02493 | DBMET02496 | |
| 0.014 | 0.028 | 0.101 | Estrone sulfatase inhibitor | 0.063 0.006 DBMET02496 0.101 0.004 DBMET02498 | DBMET02498 | |
| 0.047 | 0.064 | 0.068 | Purinergic P2X2 antagonist | 0.061 0.051 DBMET02488 0.068 0.047 DBMET02490 0.068 0.047 DBMET02492 0.067 0.047 DBMET02496 0.061 0.051 DBMET02498 | DBMET02492 | |
| 0.047 | 0.069 | 0.062 | Neutrophil collagenase inhibitor | 0.062 0.048 DBMET02488 | DBMET02488 | |
| 0.027 | 0.053 | 0.051 | Dihydropteroate synthase inhibitor | 0.051 0.016 DBMET02489 0.036 0.033 DBMET02490 0.036 0.033 DBMET02492 | DBMET02489 | |
| 0.071 | 0.101 | 0.11 | Urease inhibitor | 0.092 0.076 DBMET02488 0.11 0.056 DBMET02489 0.102 0.065 DBMET02490 0.086 0.082 DBMET02491 0.102 0.065 DBMET02492 | DBMET02489 | |
| 0.042 | 0.074 | 0.055 | Epithelial sodium channel blocker | 0.055 0.037 DBMET02489 | DBMET02489 | |
| 0.046 | 0.078 | 0.071 | Nitric oxide donor | 0.066 0.039 DBMET02489 0.071 0.032 DBMET02495 0.068 0.035 DBMET02497 0.07 0.033 DBMET02494 0.068 0.035 DBMET02493 | DBMET02495 | |
| 0.193 | 0.225 | 0.457 | Calcium channel activator | 0.457 0.01 DBMET02489 | DBMET02489 | |
| 0.008 | 0.045 | 0.014 | Calcium-sensing receptor antagonist | 0.014 0.012 DBMET02489 | DBMET02489 | |
| 0.032 | 0.07 | 0.043 | VCAM-1 antagonist | 0.043 0.018 DBMET02489 | DBMET02489 | |
| 0.032 | 0.07 | 0.043 | VCAM antagonist | 0.043 0.018 DBMET02489 | DBMET02489 | |
| 0.163 | 0.204 | 0.29 | Gastrin inhibitor | 0.29 0.04 DBMET02489 | DBMET02489 | |
| 0.024 | 0.065 | 0.336 | Cholecystokinin B agonist | 0.036 0.028 DBMET02489 0.258 0.004 DBMET02496 0.336 0.003 DBMET02498 | DBMET02498 | |
| 0.11 | 0.152 | 0.214 | Adenylate cyclase stimulant | 0.136 0.089 DBMET02488 0.214 0.009 DBMET02489 0.122 0.119 DBMET02490 0.147 0.068 DBMET02491 0.122 0.119 DBMET02492 | DBMET02489 | |
| 0.11 | 0.161 | 0.359 | DNA methyltransferase I inhibitor | 0.149 0.105 DBMET02488 0.359 0.013 DBMET02489 0.143 0.112 DBMET02490 0.143 0.112 DBMET02492 0.294 0.028 DBMET02495 0.251 0.047 DBMET02497 0.176 0.083 DBMET02494 0.251 0.047 DBMET02493 | DBMET02489 | |
| 0.061 | 0.113 | 0.208 | Glutathione S-transferase inhibitor | 0.208 0.005 DBMET02489 | DBMET02489 | |
| 0.068 | 0.12 | 0.089 | Vanilloid agonist | 0.089 0.048 DBMET02488 0.085 0.058 DBMET02489 | DBMET02488 | |
| 0.172 | 0.225 | 0.372 | Apoptosis antagonist | 0.239 0.139 DBMET02488 0.356 0.053 DBMET02489 0.225 0.152 DBMET02490 0.225 0.152 DBMET02492 0.372 0.047 DBMET02495 0.36 0.051 DBMET02497 0.342 0.059 DBMET02494 0.36 0.051 DBMET02493 | DBMET02495 | |
| 0.124 | 0.181 | 0.248 | Neurotensin receptor agonist | 0.248 0.021 DBMET02489 0.144 0.117 DBMET02490 0.144 0.117 DBMET02492 | DBMET02489 | |
| 0.151 | 0.21 | 0.467 | Thyroid hormone antagonist | 0.467 0.039 DBMET02489 0.187 0.173 DBMET02491 | DBMET02489 | |
| 0.148 | 0.207 | 0.43 | Thyroid hormone beta antagonist | 0.43 0.045 DBMET02489 | DBMET02489 | |
| 0.006 | 0.066 | 0.024 | Carbonic anhydrase VIII inhibitor | 0.024 0.006 DBMET02489 | DBMET02489 | |
| 0.006 | 0.066 | 0.024 | Carbonic anhydrase X inhibitor | 0.024 0.006 DBMET02489 | DBMET02489 | |
| 0.11 | 0.173 | 0.367 | DNA methylase inhibitor | 0.158 0.111 DBMET02488 0.367 0.014 DBMET02489 0.139 0.127 DBMET02490 0.139 0.127 DBMET02492 0.316 0.024 DBMET02495 0.26 0.043 DBMET02497 0.214 0.07 DBMET02494 0.26 0.043 DBMET02493 | DBMET02489 | |
| 0.036 | 0.102 | 0.062 | Collagenase 3 inhibitor | 0.062 0.038 DBMET02489 | DBMET02489 | |
| 0.063 | 0.13 | 0.116 | Transcription factor NF kappa B stimulant | 0.093 0.047 DBMET02489 0.116 0.027 DBMET02495 0.113 0.029 DBMET02497 0.116 0.027 DBMET02494 0.113 0.029 DBMET02493 | DBMET02494 | |
| 0.111 | 0.178 | 0.142 | CC chemokine 6 receptor antagonist | 0.122 0.104 DBMET02488 0.142 0.035 DBMET02495 0.137 0.047 DBMET02497 0.137 0.047 DBMET02494 0.137 0.047 DBMET02493 | DBMET02495 | |
| 0.005 | 0.075 | 0.016 | Endothelin B receptor antagonist | 0.016 0.015 DBMET02489 | DBMET02489 | |
| 0.103 | 0.174 | 0.185 | Amyloid beta precursor protein antagonist | 0.185 0.068 DBMET02489 | DBMET02489 | |
| 0.011 | 0.086 | 0.362 | Prostacyclin antagonist | 0.362 0.003 DBMET02489 | DBMET02489 | |
| 0.071 | 0.149 | 0.121 | Phosphodiesterase 6D inhibitor | 0.121 0.024 DBMET02489 0.101 0.049 DBMET02495 0.105 0.043 DBMET02497 0.119 0.026 DBMET02494 0.105 0.043 DBMET02493 | DBMET02489 | |
| 0.065 | 0.144 | 0.143 | Estrogen-related receptor beta agonist | 0.079 0.069 DBMET02488 0.143 0.005 DBMET02489 0.079 0.071 DBMET02491 | DBMET02489 | |
| 0.056 | 0.137 | 0.15 | Sphingomyelinase inhibitor | 0.15 0.024 DBMET02489 | DBMET02489 | |
| 0.063 | 0.143 | 0.168 | Granulocyte macrophage colony stimulating factor agonist | 0.168 0.004 DBMET02489 | DBMET02489 | |
| 0.006 | 0.088 | 0.174 | Cholecystokinin agonist | 0.128 0.004 DBMET02496 0.174 0.003 DBMET02498 | DBMET02498 | |
| 0.007 | 0.088 | 0.15 | Cholecystokinin A agonist | 0.12 0.004 DBMET02496 0.15 0.003 DBMET02498 | DBMET02498 | |
| 0.049 | 0.133 | 0.075 | Phosphodiesterase VI inhibitor | 0.075 0.051 DBMET02489 | DBMET02489 | |
| 0.012 | 0.096 | 0.17 | Peroxisome proliferator-activated receptor delta agonist | 0.17 0.004 DBMET02489 | DBMET02489 | |
| 0.009 | 0.095 | 0.031 | Endothelin receptor antagonist | 0.031 0.017 DBMET02489 | DBMET02489 | |
| 0.004 | 0.092 | 0.032 | Ileal bile acid transport inhibitor | 0.032 0.005 DBMET02489 0.018 0.011 DBMET02495 | DBMET02489 | |
| 0.018 | 0.11 | 0.083 | Sphingosine 1-phosphate receptor 1 agonist | 0.083 0.005 DBMET02489 | DBMET02489 | |
| 0.061 | 0.159 | 0.172 | Interleukin 1 beta converting enzyme inhibitor | 0.172 0.011 DBMET02489 | DBMET02489 | |
| 0.032 | 0.134 | 0.048 | Phosphodiesterase 6C inhibitor | 0.048 0.026 DBMET02489 | DBMET02489 | |
| 0.147 | 0.248 | 0.179 | Transcription factor STAT inhibitor | 0.179 0.169 DBMET02488 | DBMET02488 | |
| 0.061 | 0.167 | 0.103 | Tubulin antagonist | 0.103 0.098 DBMET02489 | DBMET02489 | |
| 0.013 | 0.119 | 0.068 | Lysophosphatidic acid 2 receptor antagonist | 0.068 0.005 DBMET02489 | DBMET02489 | |
| 0.016 | 0.129 | 0.273 | Peroxisome proliferator-activated receptor delta antagonist | 0.273 0.003 DBMET02489 | DBMET02489 | |
| 0.044 | 0.158 | 0.188 | Aminopeptidase B inhibitor | 0.188 0.024 DBMET02489 0.083 0.079 DBMET02491 | DBMET02489 | |
| 0.019 | 0.134 | 0.101 | Sphingosine 1-phosphate receptor agonist | 0.101 0.005 DBMET02489 | DBMET02489 | |
| 0.087 | 0.202 | 0.122 | Thiol protease inhibitor | 0.122 0.113 DBMET02489 | DBMET02489 | |
| 0.118 | 0.234 | 0.169 | Histone acetyltransferase inhibitor | 0.169 0.114 DBMET02489 | DBMET02489 | |
| 0.071 | 0.19 | 0.214 | Cell adhesion inhibitor | 0.214 0.021 DBMET02489 0.174 0.033 DBMET02495 0.18 0.031 DBMET02497 0.191 0.027 DBMET02494 0.18 0.031 DBMET02493 | DBMET02489 | |
| 0.017 | 0.135 | 0.027 | Toll-Like receptor 4 agonist | 0.027 0.017 DBMET02495 0.027 0.018 DBMET02497 0.026 0.018 DBMET02494 0.027 0.018 DBMET02493 | DBMET02493 | |
| 0.131 | 0.251 | 0.184 | ErbB-1 antagonist | 0.184 0.109 DBMET02489 | DBMET02489 | |
| 0.081 | 0.202 | 0.399 | Dual specificity phosphatase 3 inhibitor | 0.399 0.014 DBMET02489 0.239 0.044 DBMET02496 0.243 0.043 DBMET02498 | DBMET02489 | |
| 0.087 | 0.208 | 0.461 | Anesthetic general | 0.461 0.01 DBMET02489 | DBMET02489 | |
| 0.022 | 0.146 | 0.041 | Calcium-independent phospholipase A2 inhibitor | 0.041 0.009 DBMET02489 | DBMET02489 | |
| 0.06 | 0.186 | 0.248 | Bone formation stimulant | 0.248 0.025 DBMET02489 | DBMET02489 | |
| 0.006 | 0.133 | 0.028 | Squalene synthetase inhibitor | 0.028 0.026 DBMET02489 | DBMET02489 | |
| 0.039 | 0.168 | 0.121 | Phosphodiesterase 1C inhibitor | 0.121 0.006 DBMET02489 | DBMET02489 | |
| 0.025 | 0.154 | 0.067 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.067 0.023 DBMET02489 | DBMET02489 | |
| 0.093 | 0.223 | 0.22 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.22 0.089 DBMET02489 | DBMET02489 | |
| 0.135 | 0.267 | 0.324 | Nitric-oxide synthase stimulant | 0.324 0.007 DBMET02489 | DBMET02489 | |
| 0.027 | 0.159 | 0.169 | Sphingosine 1-phosphate receptor 4 agonist | 0.169 0.006 DBMET02489 | DBMET02489 | |
| 0.008 | 0.141 | 0.019 | Antibiotic Anthracycline-like | 0.019 0.012 DBMET02489 0.019 0.013 DBMET02495 | DBMET02495 | |
| 0.016 | 0.149 | 0.08 | Fructose-1,6-bisphosphatase inhibitor | 0.08 0.007 DBMET02489 | DBMET02489 | |
| 0.058 | 0.195 | 0.167 | Caspase 3 inhibitor | 0.167 0.018 DBMET02489 | DBMET02489 | |
| 0.005 | 0.142 | 0.08 | Thyroid hormone alpha antagonist | 0.08 0.004 DBMET02489 | DBMET02489 | |
| 0.047 | 0.184 | 0.132 | Cell adhesion molecule inhibitor | 0.132 0.02 DBMET02489 0.089 0.044 DBMET02495 0.094 0.039 DBMET02497 0.101 0.034 DBMET02494 0.094 0.039 DBMET02493 | DBMET02489 | |
| 0.02 | 0.158 | 0.102 | Lysophosphatidic acid 3 receptor antagonist | 0.102 0.005 DBMET02489 | DBMET02489 | |
| 0.084 | 0.224 | 0.162 | Interleukin antagonist | 0.162 0.109 DBMET02494 | DBMET02494 | |
| 0.146 | 0.288 | 0.24 | Caspase 3 stimulant | 0.209 0.156 DBMET02489 0.199 0.17 DBMET02490 0.199 0.17 DBMET02492 0.214 0.149 DBMET02495 0.24 0.121 DBMET02497 0.205 0.161 DBMET02494 0.24 0.121 DBMET02493 | DBMET02493 | |
| 0.083 | 0.225 | 0.137 | Growth hormone agonist | 0.137 0.099 DBMET02489 | DBMET02489 | |
| 0.023 | 0.166 | 0.056 | Kainate receptor agonist | 0.056 0.009 DBMET02489 | DBMET02489 | |
| 0.172 | 0.318 | 0.453 | Apoptosis agonist | 0.269 0.196 DBMET02488 0.264 0.2 DBMET02489 0.263 0.201 DBMET02490 0.263 0.201 DBMET02492 0.446 0.093 DBMET02495 0.453 0.09 DBMET02497 0.425 0.102 DBMET02494 0.453 0.09 DBMET02493 | DBMET02493 | |
| 0.058 | 0.205 | 0.092 | Toll-Like receptor 3 antagonist | 0.092 0.065 DBMET02489 | DBMET02489 | |
| 0.055 | 0.202 | 0.296 | Mucolytic | 0.296 0.004 DBMET02489 | DBMET02489 | |
| 0.014 | 0.165 | 0.047 | Potassium channel Kv1.3 blocker | 0.047 0.032 DBMET02489 | DBMET02489 | |
| 0.031 | 0.184 | 0.129 | Aminopeptidase I inhibitor | 0.129 0.017 DBMET02489 | DBMET02489 | |
| 0.13 | 0.284 | 0.599 | Antithrombotic | 0.512 0.027 DBMET02489 0.594 0.017 DBMET02495 0.215 0.16 DBMET02496 0.564 0.02 DBMET02497 0.237 0.137 DBMET02498 0.599 0.016 DBMET02494 0.564 0.02 DBMET02493 | DBMET02494 | |
| 0.057 | 0.215 | 0.14 | Toll-Like receptor 4 antagonist | 0.14 0.027 DBMET02489 0.13 0.034 DBMET02495 0.136 0.03 DBMET02497 0.134 0.031 DBMET02494 0.136 0.03 DBMET02493 | DBMET02489 | |
| 0.008 | 0.167 | 0.092 | Prostaglandin EP4 antagonist | 0.092 0.005 DBMET02489 | DBMET02489 | |
| 0.079 | 0.241 | 0.376 | Dual specificity phosphatase inhibitor | 0.376 0.017 DBMET02489 0.208 0.051 DBMET02496 0.215 0.048 DBMET02498 | DBMET02489 | |
| 0.038 | 0.201 | 0.134 | 5-Lipoxygenase inhibitor | 0.134 0.044 DBMET02489 | DBMET02489 | |
| 0.007 | 0.17 | 0.02 | Estrogen-related receptor gamma agonist | 0.02 0.011 DBMET02489 | DBMET02489 | |
| 0.051 | 0.215 | 0.085 | Interleukin 5 antagonist | 0.085 0.062 DBMET02489 | DBMET02489 | |
| 0.041 | 0.208 | 0.077 | Histamine H2 receptor antagonist | 0.077 0.072 DBMET02489 | DBMET02489 | |
| 0.024 | 0.191 | 0.063 | Phosphodiesterase 5A inhibitor | 0.063 0.058 DBMET02489 | DBMET02489 | |
| 0.019 | 0.188 | 0.294 | Peroxisome proliferator-activated receptor gamma agonist | 0.294 0.005 DBMET02489 | DBMET02489 | |
| 0.111 | 0.282 | 0.519 | Transcription factor NF kappa B inhibitor | 0.398 0.064 DBMET02489 0.214 0.156 DBMET02490 0.199 0.17 DBMET02491 0.214 0.156 DBMET02492 0.505 0.043 DBMET02495 0.519 0.041 DBMET02497 0.476 0.048 DBMET02494 0.519 0.041 DBMET02493 | DBMET02493 | |
| 0.023 | 0.194 | 0.063 | Phosphodiesterase V inhibitor | 0.063 0.06 DBMET02489 | DBMET02489 | |
| 0.043 | 0.215 | 0.076 | Calcium channel P-type blocker | 0.076 0.019 DBMET02489 | DBMET02489 | |
| 0.104 | 0.276 | 0.336 | Lipoxygenase inhibitor | 0.189 0.152 DBMET02488 0.336 0.055 DBMET02489 0.183 0.16 DBMET02490 0.181 0.162 DBMET02491 0.183 0.16 DBMET02492 | DBMET02489 | |
| 0.005 | 0.181 | 0.03 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.03 0.008 DBMET02489 | DBMET02489 | |
| 0.01 | 0.186 | 0.196 | Peroxisome proliferator-activated receptor alpha agonist | 0.196 0.004 DBMET02489 | DBMET02489 | |
| 0.109 | 0.286 | 0.184 | Heat shock protein 70 antagonist | 0.184 0.01 DBMET02489 | DBMET02489 | |
| 0.038 | 0.215 | 0.146 | Peroxisome proliferator-activated receptor gamma antagonist | 0.146 0.006 DBMET02489 | DBMET02489 | |
| 0.092 | 0.27 | 0.432 | Antioxidant | 0.205 0.11 DBMET02488 0.253 0.082 DBMET02489 0.197 0.116 DBMET02490 0.167 0.145 DBMET02491 0.197 0.116 DBMET02492 0.432 0.03 DBMET02495 0.196 0.117 DBMET02496 0.432 0.03 DBMET02497 0.203 0.111 DBMET02498 0.41 0.033 DBMET02494 0.432 0.03 DBMET02493 | DBMET02493 | |
| 0.06 | 0.239 | 0.198 | Mcl-1 antagonist | 0.198 0.057 DBMET02489 | DBMET02489 | |
| 0.033 | 0.212 | 0.373 | Protein-tyrosine phosphatase 1B inhibitor | 0.373 0.006 DBMET02489 0.102 0.076 DBMET02496 0.11 0.07 DBMET02498 | DBMET02489 | |
| 0.005 | 0.185 | 0.056 | Leukotriene A4 hydrolase inhibitor | 0.056 0.017 DBMET02489 | DBMET02489 | |
| 0.006 | 0.187 | 0.032 | Isoleucine-tRNA ligase inhibitor | 0.032 0.005 DBMET02489 | DBMET02489 | |
| 0.007 | 0.189 | 0.053 | Leukotriene B4 receptor 2 antagonist | 0.053 0.004 DBMET02489 | DBMET02489 | |
| 0.009 | 0.192 | 0.032 | Lysophosphatidic acid receptor 1 agonist | 0.032 0.009 DBMET02489 | DBMET02489 | |
| 0.119 | 0.302 | 0.628 | Vasodilator, peripheral | 0.628 0.013 DBMET02489 | DBMET02489 | |
| 0.119 | 0.303 | 0.199 | Neuropeptide Y2 antagonist | 0.199 0.122 DBMET02489 | DBMET02489 | |
| 0.013 | 0.198 | 0.107 | Leukocyte elastase inhibitor | 0.107 0.009 DBMET02489 | DBMET02489 | |
| 0.057 | 0.242 | 0.105 | Electron transport complex I inhibitor | 0.105 0.072 DBMET02489 | DBMET02489 | |
| 0.013 | 0.199 | 0.038 | Estrogen-related receptor gamma antagonist | 0.038 0.006 DBMET02489 | DBMET02489 | |
| 0.015 | 0.201 | 0.033 | Melatonin receptor 1A agonist | 0.033 0.025 DBMET02489 | DBMET02489 | |
| 0.026 | 0.213 | 0.068 | Sphingosine 1-phosphate receptor 1 antagonist | 0.068 0.02 DBMET02489 | DBMET02489 | |
| 0.015 | 0.203 | 0.059 | Dihydrofolate reductase inhibitor | 0.059 0.011 DBMET02489 | DBMET02489 | |
| 0.158 | 0.346 | 0.718 | Cyclophilin D inhibitor | 0.718 0.012 DBMET02489 0.274 0.187 DBMET02491 0.599 0.027 DBMET02495 0.618 0.024 DBMET02497 0.236 0.229 DBMET02498 0.633 0.022 DBMET02494 0.618 0.024 DBMET02493 | DBMET02489 | |
| 0.082 | 0.271 | 0.4 | Free radical scavenger | 0.209 0.091 DBMET02488 0.241 0.072 DBMET02489 0.193 0.103 DBMET02490 0.193 0.103 DBMET02492 0.4 0.029 DBMET02495 0.399 0.029 DBMET02497 0.37 0.034 DBMET02494 0.399 0.029 DBMET02493 | DBMET02495 | |
| 0.062 | 0.251 | 0.114 | Interleukin 8 antagonist | 0.114 0.07 DBMET02489 | DBMET02489 | |
| 0.027 | 0.219 | 0.112 | Cathepsin G inhibitor | 0.112 0.029 DBMET02489 | DBMET02489 | |
| 0.003 | 0.196 | 0.022 | Calcium-dependent phospholipase A2 inhibitor | 0.022 0.004 DBMET02489 | DBMET02489 | |
| 0.005 | 0.198 | 0.061 | Leukotriene B4 receptor 1 antagonist | 0.061 0.005 DBMET02489 | DBMET02489 | |
| 0.047 | 0.241 | 0.201 | Lipid peroxidase inhibitor | 0.12 0.094 DBMET02488 0.147 0.07 DBMET02489 0.11 0.104 DBMET02490 0.11 0.104 DBMET02492 0.199 0.042 DBMET02495 0.201 0.041 DBMET02497 0.172 0.054 DBMET02494 0.201 0.041 DBMET02493 | DBMET02493 | |
| 0.014 | 0.209 | 0.038 | Integrin alpha2 antagonist | 0.038 0.023 DBMET02489 | DBMET02489 | |
| 0.011 | 0.207 | 0.086 | Thromboxane A2 antagonist | 0.086 0.012 DBMET02489 | DBMET02489 | |
| 0.008 | 0.205 | 0.05 | Prostaglandin F2 alpha agonist | 0.05 0.004 DBMET02489 | DBMET02489 | |
| 0.054 | 0.252 | 0.429 | Protein-tyrosine phosphatase inhibitor | 0.429 0.007 DBMET02489 0.189 0.051 DBMET02496 0.196 0.048 DBMET02498 | DBMET02489 | |
| 0.02 | 0.22 | 0.149 | Leukotriene B4 antagonist | 0.149 0.005 DBMET02489 | DBMET02489 | |
| 0.006 | 0.209 | 0.031 | Sirtuin 2 inhibitor | 0.031 0.025 DBMET02489 | DBMET02489 | |
| 0.048 | 0.253 | 0.151 | ABCA1 expression enhancer | 0.151 0.017 DBMET02489 | DBMET02489 | |
| 0.062 | 0.269 | 0.348 | Phospholipase A2 inhibitor | 0.348 0.008 DBMET02489 | DBMET02489 | |
| 0.004 | 0.211 | 0.029 | Prostaglandin EP3 antagonist | 0.029 0.022 DBMET02489 | DBMET02489 | |
| 0.034 | 0.241 | 0.39 | Expectorant | 0.39 0.005 DBMET02489 0.194 0.022 DBMET02495 0.159 0.032 DBMET02497 0.151 0.035 DBMET02494 0.159 0.032 DBMET02493 | DBMET02489 | |
| 0.016 | 0.225 | 0.054 | Elastase inhibitor | 0.054 0.036 DBMET02496 | DBMET02496 | |
| 0.002 | 0.212 | 0.13 | Peroxisome proliferator-activated receptor alpha antagonist | 0.13 0.004 DBMET02489 | DBMET02489 | |
| 0.035 | 0.244 | 0.058 | Immunoglobulin Fc receptor antagonist | 0.058 0.028 DBMET02489 | DBMET02489 | |
| 0.028 | 0.241 | 0.074 | Protease 3C (Human rhinovirus) inhibitor | 0.074 0.032 DBMET02489 | DBMET02489 | |
| 0.01 | 0.224 | 0.027 | Integrin alpha2beta1 antagonist | 0.027 0.018 DBMET02489 | DBMET02489 | |
| 0.053 | 0.268 | 0.231 | Cyclooxygenase 3 inhibitor | 0.231 0.011 DBMET02489 0.194 0.021 DBMET02495 0.184 0.025 DBMET02497 0.178 0.028 DBMET02494 0.184 0.025 DBMET02493 | DBMET02489 | |
| 0.022 | 0.239 | 0.065 | Glucose-6-phosphate translocase inhibitor | 0.065 0.019 DBMET02495 0.059 0.024 DBMET02497 0.056 0.028 DBMET02494 0.059 0.024 DBMET02493 | DBMET02495 | |
| 0.016 | 0.236 | 0.27 | Selectin antagonist | 0.072 0.041 DBMET02489 0.25 0.008 DBMET02495 0.256 0.008 DBMET02497 0.27 0.007 DBMET02494 0.256 0.008 DBMET02493 | DBMET02494 | |
| 0.069 | 0.289 | 0.18 | Sphingosine 1-phosphate receptor 2 antagonist | 0.18 0.015 DBMET02489 | DBMET02489 | |
| 0.013 | 0.235 | 0.096 | Thromboxane antagonist | 0.096 0.013 DBMET02489 | DBMET02489 | |
| 0.045 | 0.27 | 0.136 | Adenylate cyclase inhibitor | 0.136 0.055 DBMET02489 | DBMET02489 | |
| 0.018 | 0.246 | 0.277 | Catalase inhibitor | 0.277 0.007 DBMET02489 | DBMET02489 | |
| 0.015 | 0.247 | 0.041 | Neuraminidase (Influenza A) inhibitor | 0.041 0.04 DBMET02494 | DBMET02494 | |
| 0.069 | 0.304 | 0.354 | Insulin secretagoues | 0.354 0.008 DBMET02489 0.156 0.068 DBMET02495 0.174 0.052 DBMET02497 0.19 0.041 DBMET02494 0.174 0.052 DBMET02493 | DBMET02489 | |
| 0.05 | 0.286 | 0.459 | Angiogenesis stimulant | 0.216 0.086 DBMET02489 0.454 0.015 DBMET02495 0.219 0.085 DBMET02496 0.446 0.016 DBMET02497 0.223 0.083 DBMET02498 0.459 0.015 DBMET02494 0.446 0.016 DBMET02493 | DBMET02494 | |
| 0.01 | 0.249 | 0.039 | Toll-Like receptor 2 agonist | 0.039 0.03 DBMET02489 | DBMET02489 | |
| 0.029 | 0.273 | 0.138 | Ornithine decarboxylase inhibitor | 0.138 0.015 DBMET02489 | DBMET02489 | |
| 0.002 | 0.246 | 0.016 | Lysophosphatidic acid receptor 3 agonist | 0.016 0.007 DBMET02489 | DBMET02489 | |
| 0.111 | 0.356 | 0.302 | Insulysin inhibitor | 0.302 0.058 DBMET02489 | DBMET02489 | |
| 0.01 | 0.257 | 0.032 | Glutamate (mGluR1) agonist | 0.032 0.009 DBMET02489 | DBMET02489 | |
| 0.032 | 0.279 | 0.063 | Caspase 9 inhibitor | 0.063 0.042 DBMET02489 | DBMET02489 | |
| 0.009 | 0.257 | 0.209 | Prostaglandin EP2 antagonist | 0.209 0.006 DBMET02489 | DBMET02489 | |
| 0.004 | 0.255 | 0.101 | GP IIb/IIIa receptor antagonist | 0.101 0.017 DBMET02489 | DBMET02489 | |
| 0.091 | 0.342 | 0.4 | Alpha-glucosidase inhibitor | 0.25 0.188 DBMET02489 0.352 0.135 DBMET02495 0.4 0.115 DBMET02497 0.257 0.183 DBMET02494 0.4 0.115 DBMET02493 | DBMET02493 | |
| 0.062 | 0.314 | 0.167 | P-glycoprotein inhibitor | 0.167 0.093 DBMET02489 | DBMET02489 | |
| 0.018 | 0.27 | 0.291 | Phenylalanine 4-hydroxylase inhibitor | 0.291 0.004 DBMET02489 | DBMET02489 | |
| 0.059 | 0.314 | 0.44 | Hypolipemic | 0.44 0.019 DBMET02489 0.177 0.112 DBMET02495 0.192 0.101 DBMET02497 0.172 0.117 DBMET02494 0.192 0.101 DBMET02493 | DBMET02489 | |
| 0.147 | 0.402 | 0.424 | Calcium channel L-type activator | 0.424 0.066 DBMET02489 | DBMET02489 | |
| 0.006 | 0.262 | 0.036 | Lysophosphatidic acid 1 receptor antagonist | 0.036 0.005 DBMET02489 | DBMET02489 | |
| 0.017 | 0.276 | 0.054 | Cytokine production stimulant | 0.054 0.02 DBMET02489 | DBMET02489 | |
| 0.006 | 0.267 | 0.032 | 1,3-Beta-glucan synthase inhibitor | 0.032 0.01 DBMET02496 | DBMET02496 | |
| 0.078 | 0.339 | 0.189 | Thioredoxin glutathione reductase inhibitor | 0.189 0.182 DBMET02489 | DBMET02489 | |
| 0.044 | 0.305 | 0.12 | Cathepsin H inhibitor | 0.12 0.075 DBMET02489 | DBMET02489 | |
| 0.024 | 0.286 | 0.1 | Phosphodiesterase 1B inhibitor | 0.1 0.014 DBMET02489 | DBMET02489 | |
| 0.008 | 0.27 | 0.027 | Protein 30S ribosomal subunit inhibitor | 0.024 0.016 DBMET02495 0.024 0.017 DBMET02497 0.027 0.015 DBMET02494 0.024 0.017 DBMET02493 | DBMET02494 | |
| 0.008 | 0.271 | 0.025 | Vanilloid 2 agonist | 0.025 0.017 DBMET02489 | DBMET02489 | |
| 0.014 | 0.278 | 0.165 | Leukotriene antagonist | 0.165 0.008 DBMET02489 | DBMET02489 | |
| 0.017 | 0.283 | 0.326 | Histidine decarboxylase inhibitor | 0.326 0.005 DBMET02489 | DBMET02489 | |
| 0.045 | 0.313 | 0.212 | Toll-Like receptor 2 antagonist | 0.212 0.019 DBMET02489 | DBMET02489 | |
| 0.017 | 0.286 | 0.076 | Sphingosine 1-phosphate receptor 3 antagonist | 0.076 0.02 DBMET02489 | DBMET02489 | |
| 0.03 | 0.304 | 0.152 | Alkylator | 0.152 0.045 DBMET02489 0.114 0.073 DBMET02495 0.1 0.088 DBMET02497 0.098 0.091 DBMET02494 0.1 0.088 DBMET02493 | DBMET02489 | |
| 0.005 | 0.279 | 0.042 | Phosphoglycerate kinase inhibitor | 0.042 0.018 DBMET02489 | DBMET02489 | |
| 0.084 | 0.359 | 0.284 | DNA polymerase beta inhibitor | 0.284 0.174 DBMET02489 | DBMET02489 | |
| 0.029 | 0.307 | 0.178 | Gastric antisecretory | 0.178 0.017 DBMET02489 | DBMET02489 | |
| 0.024 | 0.304 | 0.239 | Macrophage migration inhibitory factor inhibitor | 0.239 0.005 DBMET02489 | DBMET02489 | |
| 0.058 | 0.34 | 0.378 | Platelet adhesion inhibitor | 0.378 0.014 DBMET02489 0.277 0.041 DBMET02495 0.278 0.041 DBMET02497 0.151 0.104 DBMET02498 0.326 0.026 DBMET02494 0.278 0.041 DBMET02493 | DBMET02489 | |
| 0.009 | 0.292 | 0.059 | Glutamate (mGluR3) antagonist | 0.059 0.009 DBMET02489 | DBMET02489 | |
| 0.061 | 0.344 | 0.297 | Hepatoprotectant | 0.206 0.061 DBMET02489 0.295 0.031 DBMET02495 0.297 0.03 DBMET02497 0.29 0.033 DBMET02494 0.297 0.03 DBMET02493 | DBMET02493 | |
| 0.011 | 0.296 | 0.066 | Prostaglandin-E synthase inhibitor | 0.066 0.053 DBMET02489 | DBMET02489 | |
| 0.005 | 0.294 | 0.036 | Leukotriene D4 antagonist | 0.036 0.013 DBMET02489 | DBMET02489 | |
| 0.012 | 0.302 | 0.046 | Tryptophan 5 hydroxylase inhibitor | 0.046 0.007 DBMET02489 | DBMET02489 | |
| 0.002 | 0.294 | 0.04 | Prostaglandin H2 antagonist | 0.04 0.006 DBMET02489 | DBMET02489 | |
| 0.029 | 0.32 | 0.094 | Nitric-oxide synthase inhibitor | 0.094 0.07 DBMET02489 | DBMET02489 | |
| 0.086 | 0.379 | 0.157 | Catenin beta inhibitor | 0.157 0.09 DBMET02489 | DBMET02489 | |
| 0.011 | 0.304 | 0.063 | HIV-1 integrase (3'-Processing) inhibitor | 0.061 0.046 DBMET02489 0.063 0.044 DBMET02496 0.056 0.052 DBMET02498 | DBMET02496 | |
| 0.035 | 0.328 | 0.117 | Thioredoxin inhibitor | 0.117 0.033 DBMET02489 0.084 0.073 DBMET02497 0.084 0.073 DBMET02493 | DBMET02489 | |
| 0.025 | 0.319 | 0.067 | Interferon inducer | 0.067 0.04 DBMET02489 | DBMET02489 | |
| 0.004 | 0.302 | 0.067 | Uridine phosphorylase inhibitor | 0.067 0.004 DBMET02489 | DBMET02489 | |
| 0.063 | 0.361 | 0.169 | 3C-like protease (Human coronavirus) inhibitor | 0.169 0.075 DBMET02489 | DBMET02489 | |
| 0.018 | 0.317 | 0.055 | Squalene epoxidase inhibitor | 0.055 0.026 DBMET02489 | DBMET02489 | |
| 0.006 | 0.308 | 0.021 | Neuraminidase (Influenza B) inhibitor | 0.021 0.014 DBMET02489 | DBMET02489 | |
| 0.043 | 0.345 | 0.185 | Photosensitizer | 0.185 0.016 DBMET02489 | DBMET02489 | |
| 0.063 | 0.367 | 0.597 | Succinate dehydrogenase inhibitor | 0.597 0.002 DBMET02489 | DBMET02489 | |
| 0.058 | 0.366 | 0.252 | Hemostatic | 0.162 0.055 DBMET02489 0.239 0.023 DBMET02495 0.19 0.037 DBMET02496 0.252 0.022 DBMET02497 0.165 0.053 DBMET02498 0.241 0.023 DBMET02494 0.252 0.022 DBMET02493 | DBMET02493 | |
| 0.011 | 0.318 | 0.06 | Liver X receptor alpha agonist | 0.06 0.013 DBMET02489 | DBMET02489 | |
| 0.032 | 0.342 | 0.125 | Phosphodiesterase I inhibitor | 0.125 0.025 DBMET02489 | DBMET02489 | |
| 0.004 | 0.314 | 0.3 | Prostaglandin D2 antagonist | 0.3 0.003 DBMET02489 | DBMET02489 | |
| 0.03 | 0.341 | 0.105 | Chelator | 0.105 0.071 DBMET02489 | DBMET02489 | |
| 0.015 | 0.326 | 0.055 | Antibiotic Aminoglycoside-like | 0.053 0.011 DBMET02495 0.052 0.012 DBMET02497 0.055 0.011 DBMET02494 0.052 0.012 DBMET02493 | DBMET02494 | |
| 0.133 | 0.446 | 0.608 | 5 Hydroxytryptamine release inhibitor | 0.608 0.01 DBMET02489 | DBMET02489 | |
| 0.043 | 0.357 | 0.172 | Glutamate (mGluR7) agonist | 0.172 0.007 DBMET02489 | DBMET02489 | |
| 0.002 | 0.316 | 0.058 | G-protein-coupled receptor 120 agonist | 0.058 0.004 DBMET02489 | DBMET02489 | |
| 0.018 | 0.336 | 0.141 | NMDA receptor agonist | 0.141 0.009 DBMET02489 | DBMET02489 | |
| 0.063 | 0.381 | 0.13 | CF transmembrane conductance regulator agonist | 0.13 0.119 DBMET02489 | DBMET02489 | |
| 0.026 | 0.344 | 0.089 | Sphingosine 1-phosphate receptor antagonist | 0.089 0.032 DBMET02489 | DBMET02489 | |
| 0.013 | 0.334 | 0.268 | Monophenol monooxygenase inhibitor | 0.268 0.022 DBMET02489 0.088 0.085 DBMET02495 0.11 0.068 DBMET02497 0.11 0.068 DBMET02493 | DBMET02489 | |
| 0.007 | 0.328 | 0.027 | Caspase 8 inhibitor | 0.027 0.006 DBMET02489 | DBMET02489 | |
| 0.003 | 0.326 | 0.019 | Vitamin D receptor agonist | 0.019 0.008 DBMET02489 | DBMET02489 | |
| 0.022 | 0.346 | 0.085 | Interferon agonist | 0.085 0.044 DBMET02489 | DBMET02489 | |
| 0.013 | 0.339 | 0.07 | Protein 50S ribosomal subunit inhibitor | 0.07 0.024 DBMET02495 0.066 0.026 DBMET02497 0.069 0.025 DBMET02494 0.066 0.026 DBMET02493 | DBMET02495 | |
| 0.007 | 0.335 | 0.05 | Dopamine D5 agonist | 0.05 0.018 DBMET02489 | DBMET02489 | |
| 0.017 | 0.346 | 0.093 | Inducible nitric-oxide synthase inhibitor | 0.093 0.044 DBMET02489 | DBMET02489 | |
| 0.01 | 0.339 | 0.055 | Neuraminidase inhibitor | 0.055 0.051 DBMET02489 | DBMET02489 | |
| 0.006 | 0.337 | 0.031 | Liver X receptor beta antagonist | 0.031 0.018 DBMET02489 | DBMET02489 | |
| 0.007 | 0.34 | 0.076 | Thyroid hormone agonist | 0.076 0.003 DBMET02489 | DBMET02489 | |
| 0.055 | 0.389 | 0.329 | Tumour necrosis factor alpha release inhibitor | 0.318 0.047 DBMET02489 0.329 0.044 DBMET02495 0.264 0.068 DBMET02497 0.217 0.095 DBMET02494 0.264 0.068 DBMET02493 | DBMET02495 | |
| 0.023 | 0.357 | 0.255 | Cholesterol synthesis inhibitor | 0.255 0.017 DBMET02489 | DBMET02489 | |
| 0.031 | 0.365 | 0.055 | Lipocortins synthesis agonist | 0.055 0.05 DBMET02489 | DBMET02489 | |
| 0.047 | 0.383 | 0.242 | Nitric oxide antagonist | 0.145 0.1 DBMET02489 0.242 0.054 DBMET02495 0.24 0.054 DBMET02497 0.219 0.061 DBMET02494 0.24 0.054 DBMET02493 | DBMET02495 | |
| 0.014 | 0.351 | 0.091 | Sphingosine 1-phosphate receptor 5 agonist | 0.091 0.01 DBMET02489 | DBMET02489 | |
| 0.021 | 0.359 | 0.07 | Phosphodiesterase 1A inhibitor | 0.07 0.024 DBMET02489 | DBMET02489 | |
| 0.004 | 0.346 | 0.051 | Thyroid hormone alpha agonist | 0.051 0.003 DBMET02489 | DBMET02489 | |
| 0.007 | 0.349 | 0.087 | Prostaglandin E2 antagonist | 0.087 0.018 DBMET02489 | DBMET02489 | |
| 0.008 | 0.351 | 0.063 | HIV-1 integrase (Strand Transfer) inhibitor | 0.063 0.04 DBMET02489 0.053 0.047 DBMET02496 | DBMET02489 | |
| 0.037 | 0.382 | 0.122 | Estrogen antagonist | 0.122 0.051 DBMET02489 0.104 0.088 DBMET02490 0.104 0.088 DBMET02492 | DBMET02489 | |
| 0.071 | 0.418 | 0.266 | Hypoxia-inducible factor 1 alpha inhibitor | 0.266 0.087 DBMET02489 | DBMET02489 | |
| 0.041 | 0.388 | 0.386 | Immunostimulant | 0.299 0.079 DBMET02489 0.356 0.063 DBMET02495 0.358 0.062 DBMET02497 0.386 0.054 DBMET02494 0.358 0.062 DBMET02493 | DBMET02494 | |
| 0.017 | 0.366 | 0.072 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.072 0.055 DBMET02489 | DBMET02489 | |
| 0.004 | 0.354 | 0.033 | Sodium/glucose cotransporter 2 inhibitor | 0.033 0.011 DBMET02489 | DBMET02489 | |
| 0.017 | 0.368 | 0.07 | Topoisomerase II alpha inhibitor | 0.07 0.062 DBMET02497 0.07 0.062 DBMET02493 | DBMET02493 | |
| 0.017 | 0.368 | 0.075 | Phospholipase D inhibitor | 0.075 0.043 DBMET02489 | DBMET02489 | |
| 0.024 | 0.375 | 0.058 | Ryanodine receptor antagonist | 0.058 0.043 DBMET02489 | DBMET02489 | |
| 0.037 | 0.392 | 0.132 | Amyloid beta aggregation inhibitor | 0.132 0.123 DBMET02489 | DBMET02489 | |
| 0.044 | 0.399 | 0.662 | Platelet antagonist | 0.662 0.005 DBMET02489 0.193 0.107 DBMET02495 0.184 0.114 DBMET02497 0.215 0.091 DBMET02494 0.184 0.114 DBMET02493 | DBMET02489 | |
| 0.018 | 0.373 | 0.206 | M17 leucyl aminopeptidase inhibitor | 0.206 0.031 DBMET02489 | DBMET02489 | |
| 0.013 | 0.369 | 0.061 | Neuraminidase (influenza) inhibitor | 0.061 0.051 DBMET02489 | DBMET02489 | |
| 0.005 | 0.364 | 0.087 | Ornithine carbamoyltransferase inhibitor | 0.087 0.019 DBMET02489 | DBMET02489 | |
| 0.024 | 0.383 | 0.065 | DNA helicase inhibitor | 0.065 0.021 DBMET02489 | DBMET02489 | |
| 0.011 | 0.371 | 0.094 | Phosphodiesterase IV inhibitor | 0.094 0.05 DBMET02489 | DBMET02489 | |
| 0.025 | 0.386 | 0.261 | Keratolytic | 0.261 0.005 DBMET02489 | DBMET02489 | |
| 0.016 | 0.377 | 0.091 | Glutamate (mGluR4) antagonist | 0.091 0.006 DBMET02489 | DBMET02489 | |
| 0.005 | 0.366 | 0.04 | Liver X receptor beta agonist | 0.04 0.015 DBMET02489 | DBMET02489 | |
| 0.017 | 0.379 | 0.068 | Heparanase inhibitor | 0.065 0.016 DBMET02489 0.056 0.03 DBMET02495 0.062 0.02 DBMET02497 0.068 0.013 DBMET02494 0.062 0.02 DBMET02493 | DBMET02494 | |
| 0.027 | 0.39 | 0.124 | Multidrug resistance-associated protein 1 inhibitor | 0.114 0.056 DBMET02496 0.124 0.044 DBMET02498 | DBMET02498 | |
| 0.023 | 0.385 | 0.124 | ATPase (Vacuolar H+) inhibitor | 0.124 0.017 DBMET02489 0.089 0.059 DBMET02495 0.089 0.058 DBMET02497 0.088 0.059 DBMET02494 0.089 0.058 DBMET02493 | DBMET02489 | |
| 0.069 | 0.434 | 0.33 | 15-Lipoxygenase inhibitor | 0.33 0.111 DBMET02489 | DBMET02489 | |
| 0.01 | 0.376 | 0.051 | Glutamate (mGluR3) agonist | 0.051 0.005 DBMET02489 | DBMET02489 | |
| 0.021 | 0.39 | 0.242 | CD45 antagonist | 0.242 0.004 DBMET02489 | DBMET02489 | |
| 0.022 | 0.391 | 0.101 | Myeloperoxidase inhibitor | 0.101 0.034 DBMET02489 | DBMET02489 | |
| 0.027 | 0.399 | 0.302 | Thrombolytic | 0.302 0.024 DBMET02489 0.214 0.046 DBMET02495 0.193 0.055 DBMET02497 0.208 0.048 DBMET02494 0.193 0.055 DBMET02493 | DBMET02489 | |
| 0.054 | 0.426 | 0.217 | Tumour necrosis factor antagonist | 0.217 0.044 DBMET02489 | DBMET02489 | |
| 0.031 | 0.405 | 0.328 | Amylase inhibitor | 0.328 0.015 DBMET02489 0.164 0.057 DBMET02495 0.187 0.049 DBMET02497 0.137 0.071 DBMET02494 0.187 0.049 DBMET02493 | DBMET02489 | |
| 0.059 | 0.434 | 0.287 | DNA directed DNA polymerase inhibitor | 0.287 0.168 DBMET02489 | DBMET02489 | |
| 0.071 | 0.453 | 0.31 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.31 0.02 DBMET02489 | DBMET02489 | |
| 0.006 | 0.388 | 0.429 | Prostaglandin antagonist | 0.429 0.004 DBMET02489 | DBMET02489 | |
| 0.003 | 0.387 | 0.138 | Prostacyclin agonist | 0.138 0.003 DBMET02489 | DBMET02489 | |
| 0.004 | 0.39 | 0.081 | Free fatty acid receptor 1 antagonist | 0.081 0.004 DBMET02489 | DBMET02489 | |
| 0.004 | 0.393 | 0.045 | Geranyltranstransferase inhibitor | 0.045 0.029 DBMET02489 | DBMET02489 | |
| 0.05 | 0.441 | 0.13 | DNA repair enzyme inhibitor | 0.13 0.055 DBMET02489 0.114 0.085 DBMET02495 0.11 0.095 DBMET02497 0.118 0.077 DBMET02494 0.11 0.095 DBMET02493 | DBMET02489 | |
| 0.062 | 0.454 | 0.189 | Sphingosine 1-phosphate receptor 5 antagonist | 0.189 0.017 DBMET02489 | DBMET02489 | |
| 0.002 | 0.397 | 0.039 | Arginase inhibitor | 0.039 0.023 DBMET02489 | DBMET02489 | |
| 0.013 | 0.41 | 0.062 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.062 0.006 DBMET02489 | DBMET02489 | |
| 0.051 | 0.449 | 0.365 | Cyclic AMP phosphodiesterase inhibitor | 0.365 0.022 DBMET02489 | DBMET02489 | |
| 0.007 | 0.407 | 0.031 | Purinergic P2X3 antagonist | 0.031 0.029 DBMET02489 | DBMET02489 | |
| 0.011 | 0.412 | 0.061 | Retinoid X alpha receptor antagonist | 0.061 0.004 DBMET02489 | DBMET02489 | |
| 0.011 | 0.415 | 0.071 | Retinoid X receptor antagonist | 0.071 0.004 DBMET02489 | DBMET02489 | |
| 0.005 | 0.409 | 0.03 | Sodium/glucose cotransporter inhibitor | 0.03 0.011 DBMET02489 | DBMET02489 | |
| 0.005 | 0.412 | 0.033 | Retinoid X gamma receptor antagonist | 0.033 0.009 DBMET02489 | DBMET02489 | |
| 0.011 | 0.42 | 0.224 | Glutamate decarboxylase inhibitor | 0.224 0.005 DBMET02489 | DBMET02489 | |
| 0.012 | 0.421 | 0.079 | Phosphodiesterase III inhibitor | 0.079 0.036 DBMET02489 | DBMET02489 | |
| 0.046 | 0.456 | 0.17 | Melanin inhibitor | 0.17 0.059 DBMET02489 | DBMET02489 | |
| 0.033 | 0.447 | 0.147 | Cytokine production inhibitor | 0.147 0.064 DBMET02489 | DBMET02489 | |
| 0.001 | 0.416 | 0.035 | Thyroid hormone beta agonist | 0.035 0.003 DBMET02489 | DBMET02489 | |
| 0.022 | 0.438 | 0.155 | Anabolic | 0.155 0.015 DBMET02489 | DBMET02489 | |
| 0.004 | 0.422 | 0.039 | Retinoid X beta receptor antagonist | 0.039 0.003 DBMET02489 | DBMET02489 | |
| 0.007 | 0.427 | 0.082 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.082 0.024 DBMET02489 | DBMET02489 | |
| 0.028 | 0.448 | 0.117 | Antibacterial (Helicobacter pylori) | 0.117 0.085 DBMET02489 | DBMET02489 | |
| 0.003 | 0.425 | 0.024 | Retinoid X beta receptor agonist | 0.024 0.011 DBMET02489 | DBMET02489 | |
| 0.02 | 0.446 | 0.179 | Glutamate dehydrogenase inhibitor | 0.179 0.012 DBMET02489 | DBMET02489 | |
| 0.004 | 0.431 | 0.055 | Cholecystokinin A antagonist | 0.039 0.025 DBMET02496 0.055 0.018 DBMET02498 | DBMET02498 | |
| 0.004 | 0.435 | 0.02 | Integrin beta5 antagonist | 0.02 0.015 DBMET02489 | DBMET02489 | |
| 0.019 | 0.45 | 0.215 | Creatine kinase inhibitor | 0.215 0.009 DBMET02489 | DBMET02489 | |
| 0.022 | 0.453 | 0.085 | Exportin-1 inhibitor | 0.085 0.02 DBMET02489 | DBMET02489 | |
| 0.02 | 0.451 | 0.144 | Microtubule formation inhibitor | 0.144 0.041 DBMET02489 | DBMET02489 | |
| 0.009 | 0.441 | 0.084 | Thromboxane synthase inhibitor | 0.084 0.01 DBMET02489 | DBMET02489 | |
| 0.023 | 0.456 | 0.097 | Estrogen receptor alpha antagonist | 0.097 0.029 DBMET02489 | DBMET02489 | |
| 0.015 | 0.45 | 0.061 | Prostaglandin F2 alpha antagonist | 0.061 0.045 DBMET02489 | DBMET02489 | |
| 0.024 | 0.46 | 0.602 | Alpha-N-acetylglucosaminidase inhibitor | 0.602 0.004 DBMET02489 | DBMET02489 | |
| 0.013 | 0.449 | 0.059 | Vanilloid 3 antagonist | 0.059 0.005 DBMET02489 | DBMET02489 | |
| 0.041 | 0.48 | 0.128 | Antipruritic | 0.128 0.127 DBMET02489 | DBMET02489 | |
| 0.051 | 0.491 | 0.352 | Immunosuppressant | 0.28 0.128 DBMET02489 0.352 0.086 DBMET02495 0.347 0.089 DBMET02497 0.348 0.088 DBMET02494 0.347 0.089 DBMET02493 | DBMET02495 | |
| 0.02 | 0.461 | 0.329 | UDP-glucose 4-epimerase inhibitor | 0.329 0.009 DBMET02489 0.087 0.078 DBMET02494 | DBMET02489 | |
| 0.012 | 0.454 | 0.115 | Glutamate (mGluR group III) agonist | 0.115 0.008 DBMET02489 | DBMET02489 | |
| 0.042 | 0.485 | 0.134 | Glutamate release inhibitor | 0.134 0.015 DBMET02489 | DBMET02489 | |
| 0.033 | 0.479 | 0.59 | Platelet aggregation inhibitor | 0.59 0.005 DBMET02489 | DBMET02489 | |
| 0.003 | 0.449 | 0.138 | Prostaglandin agonist | 0.138 0.004 DBMET02489 | DBMET02489 | |
| 0.008 | 0.455 | 0.056 | Glutamate (mGluR4) agonist | 0.056 0.009 DBMET02489 | DBMET02489 | |
| 0.08 | 0.527 | 0.191 | Ca2+-transporting ATPase inhibitor | 0.191 0.004 DBMET02489 | DBMET02489 | |
| 0.016 | 0.464 | 0.263 | Mediator release inhibitor | 0.263 0.009 DBMET02489 | DBMET02489 | |
| 0.089 | 0.537 | 0.336 | Interleukin 2 agonist | 0.272 0.096 DBMET02489 0.323 0.059 DBMET02495 0.314 0.064 DBMET02497 0.336 0.052 DBMET02494 0.314 0.064 DBMET02493 | DBMET02494 | |
| 0.007 | 0.456 | 0.718 | Alcohol oxidase inhibitor | 0.718 0.003 DBMET02489 | DBMET02489 | |
| 0.013 | 0.471 | 0.063 | Potassium channel intermediate-conductance Ca-activated blocker | 0.063 0.036 DBMET02489 | DBMET02489 | |
| 0.016 | 0.48 | 0.094 | Caspase 7 inhibitor | 0.094 0.035 DBMET02489 | DBMET02489 | |
| 0.007 | 0.472 | 0.091 | Na+ K+ transporting ATPase inhibitor | 0.091 0.04 DBMET02489 | DBMET02489 | |
| 0.013 | 0.48 | 0.083 | Glutamate (mGluR group III) antagonist | 0.083 0.007 DBMET02489 | DBMET02489 | |
| 0.003 | 0.471 | 0.088 | Free fatty acid receptor 1 agonist | 0.088 0.004 DBMET02489 | DBMET02489 | |
| 0.006 | 0.478 | 0.086 | Acetylcholine M5 receptor agonist | 0.086 0.029 DBMET02489 | DBMET02489 | |
| 0.001 | 0.473 | 0.103 | Prostaglandin EP4 agonist | 0.103 0.004 DBMET02489 | DBMET02489 | |
| 0.014 | 0.486 | 0.095 | Pregnane X receptor antagonist | 0.095 0.004 DBMET02489 | DBMET02489 | |
| 0.058 | 0.531 | 0.391 | Toll-Like receptor 7 agonist | 0.391 0.064 DBMET02489 | DBMET02489 | |
| 0.091 | 0.568 | 0.553 | Caspase 9 stimulant | 0.553 0.044 DBMET02489 | DBMET02489 | |
| 0.011 | 0.489 | 0.065 | Glutamate (mGluR8) agonist | 0.065 0.005 DBMET02489 | DBMET02489 | |
| 0.056 | 0.535 | 0.392 | Toll-Like receptor agonist | 0.392 0.063 DBMET02489 | DBMET02489 | |
| 0.018 | 0.498 | 0.124 | Prolactin inhibitor | 0.124 0.036 DBMET02489 | DBMET02489 | |
| 0.003 | 0.484 | 0.015 | Purinergic P2Y1 agonist | 0.015 0.012 DBMET02489 | DBMET02489 | |
| 0.002 | 0.483 | 0.097 | Prostaglandin E2 agonist | 0.097 0.004 DBMET02489 | DBMET02489 | |
| 0.036 | 0.519 | 0.248 | GABA C receptor rho-2 antagonist | 0.248 0.012 DBMET02489 | DBMET02489 | |
| 0.024 | 0.507 | 0.244 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.244 0.01 DBMET02489 | DBMET02489 | |
| 0.009 | 0.492 | 0.138 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.138 0.023 DBMET02489 | DBMET02489 | |
| 0.006 | 0.491 | 0.141 | Argininosuccinate synthase inhibitor | 0.141 0.012 DBMET02489 | DBMET02489 | |
| 0.004 | 0.489 | 0.037 | Cholecystokinin antagonist | 0.037 0.031 DBMET02498 | DBMET02498 | |
| 0.022 | 0.508 | 0.064 | Adenine nucleotide translocase inhibitor | 0.064 0.022 DBMET02489 | DBMET02489 | |
| 0.011 | 0.5 | 0.294 | Alcohol dehydrogenase inhibitor | 0.294 0.005 DBMET02489 | DBMET02489 | |
| 0.004 | 0.493 | 0.114 | Retinoid X alpha receptor agonist | 0.114 0.004 DBMET02489 | DBMET02489 | |
| 0.003 | 0.496 | 0.025 | Retinoid X gamma receptor agonist | 0.025 0.014 DBMET02489 | DBMET02489 | |
| 0.023 | 0.517 | 0.261 | Prostaglandin dehydrogenase inhibitor | 0.261 0.121 DBMET02489 | DBMET02489 | |
| 0.021 | 0.517 | 0.134 | Glutamate (mGluR6) antagonist | 0.134 0.004 DBMET02489 | DBMET02489 | |
| 0.025 | 0.521 | 0.157 | DOPA decarboxylase inhibitor | 0.157 0.018 DBMET02489 | DBMET02489 | |
| 0.008 | 0.505 | 0.171 | Plasminogen activator inhibitor antagonist | 0.171 0.005 DBMET02489 | DBMET02489 | |
| 0.022 | 0.522 | 0.402 | Triose-phosphate isomerase inhibitor | 0.402 0.003 DBMET02489 | DBMET02489 | |
| 0.004 | 0.505 | 0.059 | GABA uptake inhibitor | 0.059 0.01 DBMET02489 | DBMET02489 | |
| 0.008 | 0.512 | 0.069 | Alpha-mannosidase inhibitor | 0.069 0.017 DBMET02489 | DBMET02489 | |
| 0.002 | 0.509 | 0.06 | Prostaglandin EP2 agonist | 0.06 0.004 DBMET02489 | DBMET02489 | |
| 0.035 | 0.544 | 0.36 | Interleukin agonist | 0.36 0.026 DBMET02489 | DBMET02489 | |
| 0.006 | 0.516 | 0.061 | Mannosidase inhibitor | 0.061 0.016 DBMET02489 | DBMET02489 | |
| 0.024 | 0.534 | 0.183 | NADH dehydrogenase inhibitor | 0.183 0.012 DBMET02489 | DBMET02489 | |
| 0.026 | 0.536 | 0.229 | DNA polymerase I inhibitor | 0.229 0.021 DBMET02489 | DBMET02489 | |
| 0.038 | 0.549 | 0.268 | Phospholipase C inhibitor | 0.268 0.022 DBMET02489 | DBMET02489 | |
| 0.004 | 0.52 | 0.031 | RNA-directed RNA polymerase inhibitor | 0.031 0.029 DBMET02489 | DBMET02489 | |
| 0.017 | 0.534 | 0.123 | GABA B receptor agonist | 0.123 0.007 DBMET02489 | DBMET02489 | |
| 0.023 | 0.541 | 0.111 | Acetylcholine release stimulant | 0.111 0.063 DBMET02489 | DBMET02489 | |
| 0.004 | 0.522 | 0.079 | Prostaglandin D2 agonist | 0.079 0.004 DBMET02489 | DBMET02489 | |
| 0.011 | 0.531 | 0.101 | GABA aminotransferase inhibitor | 0.101 0.026 DBMET02489 | DBMET02489 | |
| 0.004 | 0.526 | 0.078 | Antineoplastic antibiotic | 0.078 0.058 DBMET02495 0.075 0.061 DBMET02497 0.07 0.065 DBMET02494 0.075 0.061 DBMET02493 | DBMET02495 | |
| 0.005 | 0.527 | 0.238 | Phosphofructokinase-1 inhibitor | 0.238 0.008 DBMET02489 | DBMET02489 | |
| 0.032 | 0.562 | 0.25 | Adenylate kinase inhibitor | 0.25 0.01 DBMET02489 | DBMET02489 | |
| 0.021 | 0.552 | 0.111 | Bile acid receptor antagonist | 0.111 0.03 DBMET02489 | DBMET02489 | |
| 0.007 | 0.538 | 0.048 | Membrane dipeptidase inhibitor | 0.048 0.017 DBMET02489 | DBMET02489 | |
| 0.019 | 0.553 | 0.246 | Mannose-6-phosphate isomerase inhibitor | 0.246 0.013 DBMET02489 | DBMET02489 | |
| 0.007 | 0.541 | 0.074 | Leukotriene C4 antagonist | 0.074 0.004 DBMET02489 | DBMET02489 | |
| 0.013 | 0.547 | 0.208 | Cytidine deaminase inhibitor | 0.208 0.044 DBMET02489 | DBMET02489 | |
| 0.002 | 0.537 | 0.099 | Retinoid X receptor agonist | 0.099 0.005 DBMET02489 | DBMET02489 | |
| 0.005 | 0.539 | 0.178 | Aldose reductase inhibitor | 0.178 0.008 DBMET02489 | DBMET02489 | |
| 0.001 | 0.536 | 0.017 | Telomerase stimulant | 0.017 0.011 DBMET02489 | DBMET02489 | |
| 0.01 | 0.547 | 0.1 | Leukotriene C antagonist | 0.1 0.004 DBMET02489 | DBMET02489 | |
| 0.023 | 0.561 | 0.462 | Aldehyde dehydrogenase inhibitor | 0.462 0.005 DBMET02489 | DBMET02489 | |
| 0.036 | 0.574 | 0.202 | Interferon gamma antagonist | 0.202 0.04 DBMET02489 | DBMET02489 | |
| 0.009 | 0.548 | 0.116 | Leukotriene synthesis inhibitor | 0.116 0.018 DBMET02489 | DBMET02489 | |
| 0.005 | 0.546 | 0.171 | Acyl-CoA dehydrogenase inhibitor | 0.171 0.007 DBMET02489 | DBMET02489 | |
| 0.016 | 0.558 | 0.204 | Uric acid excretion stimulant | 0.204 0.013 DBMET02489 | DBMET02489 | |
| 0.006 | 0.549 | 0.056 | Dihydroorotase inhibitor | 0.056 0.019 DBMET02489 | DBMET02489 | |
| 0.001 | 0.544 | 0.021 | Glutamate (mGluR6) agonist | 0.021 0.004 DBMET02489 | DBMET02489 | |
| 0.017 | 0.561 | 0.114 | Glycine receptor agonist | 0.114 0.014 DBMET02489 | DBMET02489 | |
| 0.027 | 0.572 | 0.469 | Peroxidase inhibitor | 0.469 0.012 DBMET02489 | DBMET02489 | |
| 0.004 | 0.553 | 0.018 | Retinoic acid beta receptor agonist | 0.018 0.017 DBMET02489 | DBMET02489 | |
| 0.021 | 0.577 | 0.107 | MDM2 inhibitor | 0.107 0.005 DBMET02489 | DBMET02489 | |
| 0.027 | 0.584 | 0.275 | Interleukin 6 antagonist | 0.275 0.019 DBMET02494 | DBMET02494 | |
| 0.031 | 0.59 | 0.253 | ATPase inhibitor | 0.253 0.013 DBMET02489 | DBMET02489 | |
| 0.002 | 0.564 | 0.044 | 5-Alpha-reductase inhibitor | 0.044 0.021 DBMET02489 | DBMET02489 | |
| 0.016 | 0.58 | 0.096 | Beta glucuronidase inhibitor | 0.096 0.077 DBMET02489 | DBMET02489 | |
| 0.016 | 0.582 | 0.187 | GABA C receptor rho-1 antagonist | 0.187 0.01 DBMET02489 | DBMET02489 | |
| 0.045 | 0.612 | 0.232 | Immunomodulator | 0.221 0.141 DBMET02495 0.23 0.132 DBMET02497 0.232 0.13 DBMET02494 0.23 0.132 DBMET02493 | DBMET02494 | |
| 0.015 | 0.585 | 0.046 | CC chemokine receptor 2B antagonist | 0.046 0.041 DBMET02489 | DBMET02489 | |
| 0.01 | 0.585 | 0.109 | Glucose-6-phosphate isomerase inhibitor | 0.109 0.004 DBMET02489 | DBMET02489 | |
| 0.03 | 0.606 | 0.211 | DNA damaging | 0.211 0.107 DBMET02489 | DBMET02489 | |
| 0.005 | 0.581 | 0.02 | Methylmalonyl-CoA mutase inhibitor | 0.02 0.009 DBMET02489 | DBMET02489 | |
| 0.007 | 0.583 | 0.035 | p53 inhibitor | 0.035 0.025 DBMET02489 | DBMET02489 | |
| 0.014 | 0.592 | 0.082 | Purinergic P2X1 antagonist | 0.082 0.024 DBMET02489 | DBMET02489 | |
| 0.004 | 0.582 | 0.036 | Cholesterol ester transfer protein antagonist | 0.036 0.016 DBMET02489 | DBMET02489 | |
| 0.021 | 0.604 | 0.185 | Sphingosine 1-phosphate receptor 4 antagonist | 0.185 0.013 DBMET02489 | DBMET02489 | |
| 0.004 | 0.587 | 0.043 | Phosphodiesterase 3B inhibitor | 0.043 0.031 DBMET02489 | DBMET02489 | |
| 0.002 | 0.587 | 0.074 | Fumarate hydratase inhibitor | 0.074 0.008 DBMET02489 | DBMET02489 | |
| 0.004 | 0.592 | 0.13 | NMDA receptor glycine site agonist | 0.13 0.006 DBMET02489 | DBMET02489 | |
| 0.016 | 0.606 | 0.252 | Arachidonic acid antagonist | 0.252 0.005 DBMET02489 | DBMET02489 | |
| 0.039 | 0.632 | 0.568 | Histamine release inhibitor | 0.568 0.014 DBMET02489 | DBMET02489 | |
| 0.002 | 0.596 | 0.024 | Glutamate (mGluR1a) agonist | 0.024 0.013 DBMET02489 | DBMET02489 | |
| 0.003 | 0.606 | 0.062 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.062 0.005 DBMET02489 | DBMET02489 | |
| 0.005 | 0.608 | 0.169 | Carbamoyl phosphate synthetase inhibitor | 0.169 0.009 DBMET02489 | DBMET02489 | |
| 0.01 | 0.615 | 0.096 | Estrogen receptor beta antagonist | 0.096 0.071 DBMET02489 | DBMET02489 | |
| 0.011 | 0.615 | 0.279 | Cystathionine beta-synthase inhibitor | 0.279 0.012 DBMET02489 | DBMET02489 | |
| 0.003 | 0.609 | 0.04 | Angiotensin AT1 receptor antagonist | 0.04 0.034 DBMET02489 | DBMET02489 | |
| 0 | 0.607 | 0.015 | Thromboxane agonist | 0.015 0.005 DBMET02489 | DBMET02489 | |
| 0.006 | 0.614 | 0.294 | Aconitate hydratase inhibitor | 0.294 0.002 DBMET02489 | DBMET02489 | |
| 0.007 | 0.619 | 0.063 | Adenosine deaminase inhibitor | 0.063 0.018 DBMET02489 | DBMET02489 | |
| 0.031 | 0.645 | 0.129 | Interleukin 12 antagonist | 0.129 0.022 DBMET02489 | DBMET02489 | |
| 0.006 | 0.622 | 0.259 | Porphobilinogen synthase inhibitor | 0.259 0.007 DBMET02489 | DBMET02489 | |
| 0.015 | 0.633 | 0.245 | Xanthine oxidase inhibitor | 0.245 0.013 DBMET02489 | DBMET02489 | |
| 0.019 | 0.644 | 0.133 | Farnesoid X receptor antagonist | 0.133 0.076 DBMET02489 | DBMET02489 | |
| 0.006 | 0.631 | 0.043 | Retinoic acid alpha receptor agonist | 0.043 0.021 DBMET02489 | DBMET02489 | |
| 0.002 | 0.632 | 0.067 | Guanylate cyclase inhibitor | 0.067 0.006 DBMET02489 | DBMET02489 | |
| 0.009 | 0.639 | 0.213 | Aryl hydrocarbon receptor agonist | 0.213 0.095 DBMET02489 | DBMET02489 | |
| 0.004 | 0.636 | 0.021 | Retinoic acid gamma receptor agonist | 0.021 0.019 DBMET02489 | DBMET02489 | |
| 0.006 | 0.645 | 0.092 | CDC25B inhibitor | 0.092 0.019 DBMET02489 | DBMET02489 | |
| 0.004 | 0.644 | 0.07 | Histamine H1 receptor antagonist | 0.07 0.069 DBMET02489 | DBMET02489 | |
| 0.01 | 0.653 | 0.191 | GABA C receptor antagonist | 0.191 0.015 DBMET02489 | DBMET02489 | |
| 0.023 | 0.667 | 0.096 | D-Ala-D-Ala ligase inhibitor | 0.096 0.034 DBMET02489 | DBMET02489 | |
| 0.017 | 0.665 | 0.259 | DNA synthesis inhibitor | 0.259 0.061 DBMET02489 0.182 0.151 DBMET02494 | DBMET02489 | |
| 0.026 | 0.678 | 0.084 | T cell inhibitor | 0.084 0.053 DBMET02489 | DBMET02489 | |
| 0.002 | 0.654 | 0.036 | Kynurenine 3 monooxygenase inhibitor | 0.036 0.011 DBMET02489 | DBMET02489 | |
| 0.016 | 0.669 | 0.157 | HIV-1 integrase (Overall Integration) inhibitor | 0.157 0.023 DBMET02489 | DBMET02489 | |
| 0.004 | 0.658 | 0.141 | Xanthine dehydrogenase inhibitor | 0.141 0.008 DBMET02489 | DBMET02489 | |
| 0.01 | 0.669 | 0.3 | GABA C receptor agonist | 0.3 0.009 DBMET02489 | DBMET02489 | |
| 0.025 | 0.685 | 0.261 | Neurotrophic factor enhancer | 0.261 0.032 DBMET02489 | DBMET02489 | |
| 0.005 | 0.667 | 0.141 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.141 0.009 DBMET02489 | DBMET02489 | |
| 0.001 | 0.665 | 0.019 | Thromboxane A2 agonist | 0.019 0.006 DBMET02489 | DBMET02489 | |
| 0.041 | 0.706 | 0.513 | GABA C receptor rho-3 antagonist | 0.513 0.023 DBMET02489 | DBMET02489 | |
| 0.004 | 0.675 | 0.146 | Biliverdin reductase inhibitor | 0.146 0.01 DBMET02489 | DBMET02489 | |
| 0.016 | 0.692 | 0.073 | MAP kinase kinase 7 inhibitor | 0.073 0.071 DBMET02489 | DBMET02489 | |
| 0.009 | 0.685 | 0.073 | Adenosine A3 receptor antagonist | 0.073 0.053 DBMET02489 | DBMET02489 | |
| 0.001 | 0.68 | 0.029 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.029 0.018 DBMET02489 | DBMET02489 | |
| 0.002 | 0.686 | 0.048 | NMDA receptor subunit 3A antagonist | 0.048 0.021 DBMET02489 | DBMET02489 | |
| 0.003 | 0.691 | 0.041 | Nicotinic acid receptor agonist | 0.041 0.02 DBMET02489 | DBMET02489 | |
| 0.007 | 0.697 | 0.086 | Glutamate (mGluR7) antagonist | 0.086 0.021 DBMET02489 | DBMET02489 | |
| 0.01 | 0.704 | 0.105 | AMP-activated protein kinase stimulant | 0.105 0.064 DBMET02489 | DBMET02489 | |
| 0.002 | 0.697 | 0.046 | NMDA receptor subunit 3B antagonist | 0.046 0.028 DBMET02489 | DBMET02489 | |
| 0.02 | 0.715 | 0.499 | Antibacterial | 0.216 0.212 DBMET02489 0.499 0.041 DBMET02495 0.464 0.052 DBMET02497 0.446 0.058 DBMET02494 0.464 0.052 DBMET02493 | DBMET02495 | |
| 0.015 | 0.712 | 0.113 | TRPA1 agonist | 0.113 0.067 DBMET02489 | DBMET02489 | |
| 0.008 | 0.708 | 0.323 | Pyruvate kinase inhibitor | 0.323 0.042 DBMET02489 | DBMET02489 | |
| 0.005 | 0.719 | 0.08 | HIV-1 integrase inhibitor | 0.08 0.038 DBMET02489 | DBMET02489 | |
| 0.006 | 0.723 | 0.1 | CDC25A inhibitor | 0.1 0.028 DBMET02489 | DBMET02489 | |
| 0.009 | 0.731 | 0.058 | Transcription factor AP-1 inhibitor | 0.058 0.05 DBMET02489 | DBMET02489 | |
| 0.002 | 0.727 | 0.044 | Farnesoid X receptor agonist | 0.044 0.019 DBMET02489 | DBMET02489 | |
| 0.006 | 0.732 | 0.08 | Glycine receptor antagonist | 0.08 0.057 DBMET02489 | DBMET02489 | |
| 0.012 | 0.739 | 0.186 | Protein kinase stimulant | 0.186 0.047 DBMET02489 | DBMET02489 | |
| 0.016 | 0.747 | 0.097 | Lanosterol 14 alpha demethylase inhibitor | 0.097 0.06 DBMET02489 | DBMET02489 | |
| 0.013 | 0.745 | 0.181 | Cell wall synthesis inhibitor | 0.181 0.039 DBMET02489 | DBMET02489 | |
| 0.03 | 0.765 | 0.501 | Antiinflammatory | 0.5 0.087 DBMET02495 0.477 0.098 DBMET02497 0.501 0.087 DBMET02494 0.477 0.098 DBMET02493 | DBMET02494 | |
| 0.021 | 0.757 | 0.137 | Hexokinase inhibitor | 0.137 0.094 DBMET02489 | DBMET02489 | |
| 0.01 | 0.749 | 0.037 | Glutamate (mGluR8) antagonist | 0.037 0.022 DBMET02489 | DBMET02489 | |
| 0.01 | 0.756 | 0.098 | Potassium channel (Ca-activated) activator | 0.098 0.057 DBMET02489 | DBMET02489 | |
| 0.002 | 0.752 | 0.069 | Purinergic P2Y antagonist | 0.069 0.015 DBMET02489 | DBMET02489 | |
| 0.037 | 0.79 | 0.203 | Lipocortins synthesis antagonist | 0.203 0.054 DBMET02489 | DBMET02489 | |
| 0.001 | 0.766 | 0.022 | NMDA receptor glycine site antagonist | 0.022 0.019 DBMET02489 | DBMET02489 | |
| 0.008 | 0.777 | 0.053 | Dihydroorotate oxidase inhibitor | 0.053 0.044 DBMET02489 | DBMET02489 | |
| 0.003 | 0.774 | 0.08 | NMDA receptor antagonist | 0.08 0.066 DBMET02489 | DBMET02489 | |
| 0.056 | 0.829 | 0.373 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.373 0.127 DBMET02489 | DBMET02489 | |
| 0.019 | 0.807 | 0.303 | RNA-directed DNA polymerase inhibitor | 0.303 0.031 DBMET02489 | DBMET02489 | |
| 0.027 | 0.817 | 0.124 | NOS3 expression enhancer | 0.124 0.108 DBMET02497 0.124 0.107 DBMET02494 0.124 0.108 DBMET02493 | DBMET02493 | |
| 0.005 | 0.815 | 0.277 | Ferrochelatase inhibitor | 0.277 0.01 DBMET02489 | DBMET02489 | |
| 0.002 | 0.831 | 0.039 | GABA B receptor antagonist | 0.039 0.037 DBMET02489 | DBMET02489 | |
| 0.004 | 0.838 | 0.09 | GABA receptor agonist | 0.09 0.089 DBMET02489 | DBMET02489 | |
| 0.003 | 0.867 | 0.083 | Diacylglycerol O-acyltransferase inhibitor | 0.083 0.013 DBMET02489 | DBMET02489 | |
| 0.003 | 0.91 | 0.026 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.026 0.023 DBMET02489 | DBMET02489 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |